##### Table of Contents





UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549





FORM 10-Q







|x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ---------------------------------------------------------------------------------------

For the quarterly period ended December 27, 2009

OR



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------------

For the transition period from              to

Commission File No. 0-14225





EXAR
CORPORATION

(Exact Name of Registrant as specified in its charter)







|                                                               |  |                                        
|-------------------------------------------------------------- |  | ---------------------------------------
|Delaware                                                       |  | 94-1741481                             
|(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)

48720 Kato Road, Fremont, CA 94538

(Address of principal executive offices, Zip Code)

(510) 668-7000

(Registrants telephone number, including area
code)





Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past
90 days.    Yes  x    No   ̈

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such
files).    Yes   ̈    No   ̈

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller
reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.



|                        |  |                                                                          |  |                           |  |  
|----------------------- |  | ------------------------------------------------------------------------ |  | ------------------------- |  | -
|Large accelerated filer |  |  ̈                                                                        |  | Accelerated filer         |  | x
|                        |  |                                                                          | 
|Non-accelerated filer   |  |  ̈                          (Do not check if a smaller reporting
company) |  | Smaller reporting company |  |  ̈

Indicate by check mark whether the Registrant is a shell company (as defined in Rule
12b-2 of the Act).    Yes   ̈    No  x

The number of shares outstanding of the Registrants Common Stock was 43,816,811 as of January 29, 2010, net of 19,924,369 treasury
shares.









---

##### Table of Contents

EXAR CORPORATION AND SUBSIDIARIES

INDEX TO

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED DECEMBER 27, 2009



|         |  |                                                                                       |  |     
|-------- |  | ------------------------------------------------------------------------------------- |  | ----
|         |  |                                                                                       |  | Page
|         |  |                                                                                      
|         |  | PART IFINANCIAL INFORMATION                                                          |  |     
|         |  |                                                                                      
|Item 1.  |  | Financial Statements (Unaudited)                                                      |  | 3   
|         |  |                                                                                      
|         |  | Condensed Consolidated Balance Sheets                                                 |  | 3   
|         |  |                                                                                      
|         |  | Condensed Consolidated Statements of Operations                                       |  | 4   
|         |  |                                                                                      
|         |  | Condensed Consolidated Statements of Cash Flows                                       |  | 5   
|         |  |                                                                                      
|         |  | Notes to Condensed Consolidated Financial Statements                                  |  | 6   
|         |  |                                                                                      
|Item 2.  |  | Managements Discussion and Analysis of Financial Condition and Results of
Operations |  | 26  
|         |  |                                                                                      
|Item 3.  |  | Quantitative and Qualitative Disclosures About Market Risk                            |  | 36  
|         |  |                                                                                      
|Item 4.  |  | Controls and Procedures                                                               |  | 37  
|         |  |                                                                                      
|         |  | PART IIOTHER INFORMATION                                                             |  |     
|         |  |                                                                                      
|Item 1.  |  | Legal Proceedings                                                                     |  | 38  
|         |  |                                                                                      
|Item 1A. |  | Risk Factors                                                                          |  | 38  
|         |  |                                                                                      
|Item 6.  |  | Exhibits                                                                              |  | 52  
|         |  |                                                                                      
|         |  | Signatures                                                                            |  | 53  
|         |  |                                                                                      
|         |  | Index to Exhibits                                                                     |  | 54  



2



---

##### Table of Contents

PART IFINANCIAL INFORMATION



|ITEM 1. | FINANCIAL STATEMENTS
|------- | --------------------

EXAR CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share amounts)

(Unaudited)



|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|----------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | ---------------- | -------- | - | ------------- | - | -------- | -
|                                                                                                                                                                  |  | December 27,2009 |          |   | March 29,2009 |  
|ASSETS                                                                                                                                                            |  |                  |          |   |               |   |          |  
|Current assets:                                                                                                                                                   |  |                  |          |   |               |   |          |  
|Cash and cash equivalents                                                                                                                                         |  | $                | 22,166   |   |               | $ | 89,002   |  
|Short-term marketable securities                                                                                                                                  |  |                  | 196,090  |   |               |   | 167,341  |  
|Accounts receivable (net of allowances of $567 and $572)                                                                                                          |  |                  | 13,164   |   |               |   | 7,452    |  
|Accounts receivable, related party (net of allowances of $492 and $736)                                                                                           |  |                  | 4,472    |   |               |   | 1,796    |  
|Inventories                                                                                                                                                       |  |                  | 13,623   |   |               |   | 15,678   |  
|Other current assets                                                                                                                                              |  |                  | 4,975    |   |               |   | 3,274    |  
|Deferred income taxes                                                                                                                                             |  |                  | 289      |   |               |   | 62       |  
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|Total current assets                                                                                                                                              |  |                  | 254,779  |   |               |   | 284,605  |  
|Property, plant and equipment, net                                                                                                                                |  |                  | 43,858   |   |               |   | 42,549   |  
|Goodwill                                                                                                                                                          |  |                  | 2,621    |   |               |   |         |  
|Intangible assets, net                                                                                                                                            |  |                  | 24,917   |   |               |   | 7,359    |  
|Other non-current assets                                                                                                                                          |  |                  | 4,851    |   |               |   | 1,876    |  
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|Total assets                                                                                                                                                      |  | $                | 331,026  |   |               | $ | 336,389  |  
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|LIABILITIES AND STOCKHOLDERS EQUITY                                                                                                                              |  |                  |          |   |               |   |          |  
|Current liabilities:                                                                                                                                              |  |                  |          |   |               |   |          |  
|Accounts payable                                                                                                                                                  |  | $                | 8,198    |   |               | $ | 5,391    |  
|Accrued compensation and related benefits                                                                                                                         |  |                  | 5,533    |   |               |   | 4,773    |  
|Deferred income and allowances on sales to distributors                                                                                                           |  |                  | 3,742    |   |               |   | 3,208    |  
|Deferred income and allowances on sales to distributors, related-party                                                                                            |  |                  | 9,353    |   |               |   | 7,040    |  
|Short-term lease financing obligations                                                                                                                            |  |                  | 3,521    |   |               |   | 2,460    |  
|Other accrued expenses                                                                                                                                            |  |                  | 6,328    |   |               |   | 4,554    |  
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|Total current liabilities                                                                                                                                         |  |                  | 36,675   |   |               |   | 27,426   |  
|Long-term lease financing obligations                                                                                                                             |  |                  | 14,527   |   |               |   | 15,633   |  
|Other non-current obligations                                                                                                                                     |  |                  | 3,977    |   |               |   | 1,236    |  
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|Total liabilities                                                                                                                                                 |  |                  | 55,179   |   |               |   | 44,295   |  
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|Commitments and contingencies (Notes 16 and 17)                                                                                                                   |  |                  |          |   |               |   |          |  
|                                                                                                                                                                  |  |                 
|Stockholders equity:                                                                                                                                             |  |                  |          |   |               |   |          |  
|                                                                                                                                                                  |  |                 
|Preferred stock, $.0001 par value; 2,250,000 shares authorized; no shares outstanding                                                                             |  |                  |         |   |               |   |         |  
|Common stock, $.0001 par value; 100,000,000 shares authorized; 43,794,381 and 43,036,271 shares outstanding at December 27,
2009 and March 29, 2009, respectively |  |                  | 4        |   |               |   | 4        |  
|Additional paid-in capital                                                                                                                                        |  |                  | 718,651  |   |               |   | 710,787  |  
|Accumulated other comprehensive income                                                                                                                            |  |                  | 1,491    |   |               |   | 802      |  
|Treasury stock at cost, 19,924,369 shares at December 27, 2009 and March 29, 2009                                                                                 |  |                  | (248,983 | ) |               |   | (248,983 | )
|Accumulated deficit                                                                                                                                               |  |                  | (195,316 | ) |               |   | (170,516 | )
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|Total stockholders equity                                                                                                                                        |  |                  | 275,847  |   |               |   | 292,094  |  
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  
|Total liabilities and stockholders equity                                                                                                                        |  | $                | 331,026  |   |               | $ | 336,389  |  
|                                                                                                                                                                  |  |                  |          |   |               |   |          |  

See accompanying Notes to Condensed Consolidated Financial Statements



3



---

##### Table of Contents

EXAR CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)



|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|------------------------------------------------- |  | ------------------ | ------ | - | ----------------- | - | ------- | ---------------- |  | - | ---------------- | - |  | - | ------- | -
|                                                  |  | Three Months Ended |        |   | Nine Months Ended |  
|                                                  |  | December 27,2009   |        |   | December 28,2008  |   |         | December 27,2009 |  |   | December 28,2008 |  
|Sales:                                            |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Net sales                                         |  | $                  | 24,458 |   |                   | $ | 17,201  |                  |  | $ | 70,686           |   |  | $ | 58,953  |  
|Net sales, related party                          |  |                    | 9,473  |   |                   |   | 9,104   |                  |  |   | 25,695           |   |  |   | 32,311  |  
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Total net sales                                   |  |                    | 33,931 |   |                   |   | 26,305  |                  |  |   | 96,381           |   |  |   | 91,264  |  
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Cost of sales:                                    |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Cost of sales                                     |  |                    | 11,273 |   |                   |   | 10,821  |                  |  |   | 36,005           |   |  |   | 33,339  |  
|Cost of sales, related party                      |  |                    | 4,505  |   |                   |   | 3,998   |                  |  |   | 12,381           |   |  |   | 15,053  |  
|Amortization of purchased intangible assets       |  |                    | 1,108  |   |                   |   | 782     |                  |  |   | 4,015            |   |  |   | 2,693   |  
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Total cost of sales                               |  |                    | 16,886 |   |                   |   | 15,601  |                  |  |   | 52,401           |   |  |   | 51,085  |  
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Gross profit                                      |  |                    | 17,045 |   |                   |   | 10,704  |                  |  |   | 43,980           |   |  |   | 40,179  |  
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Operating expenses:                               |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Research and development                          |  |                    | 11,674 |   |                   |   | 8,092   |                  |  |   | 36,256           |   |  |   | 24,317  |  
|Selling, general and administrative               |  |                    | 10,688 |   |                   |   | 9,099   |                  |  |   | 37,175           |   |  |   | 30,146  |  
|Goodwill and other intangible asset impairment    |  |                    |       |   |                   |   | 59,676  |                  |  |   |                 |   |  |   | 59,676  |  
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Total operating expenses                          |  |                    | 22,362 |   |                   |   | 76,867  |                  |  |   | 73,431           |   |  |   | 114,139 |  
|Loss from operations                              |  |                    | (5,317 | ) |                   |   | (66,163 | )                |  |   | (29,451          | ) |  |   | (73,960 | )
|Other income and expense, net:                    |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Interest income and other, net                    |  |                    | 1,835  |   |                   |   | 2,570   |                  |  |   | 5,289            |   |  |   | 7,774   |  
|Interest expense                                  |  |                    | (323   | ) |                   |   | (266    | )                |  |   | (973             | ) |  |   | (927    | )
|Impairment charges on investments                 |  |                    |       |   |                   |   | (34     | )                |  |   | (317             | ) |  |   | (1,487  | )
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Total other income and expense, net               |  |                    | 1,512  |   |                   |   | 2,270   |                  |  |   | 3,999            |   |  |   | 5,360   |  
|                                                  |  |                    |        |  
|Loss before income taxes                          |  |                    | (3,805 | ) |                   |   | (63,893 | )                |  |   | (25,452          | ) |  |   | (68,600 | )
|Benefit from income taxes                         |  |                    | (43    | ) |                   |   | (70     | )                |  |   | (652             | ) |  |   | (129    | )
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Net loss                                          |  | $                  | (3,762 | ) |                   | $ | (63,823 | )                |  | $ | (24,800          | ) |  | $ | (68,471 | )
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Loss per share:                                   |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Basic and diluted loss per share                  |  | $                  | (0.09  | ) |                   | $ | (1.49   | )                |  | $ | (0.57            | ) |  | $ | (1.60   | )
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Shares used in the computation of loss per share: |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Basic and diluted                                 |  |                    | 43,648 |   |                   |   | 42,889  |                  |  |   | 43,504           |   |  |   | 42,866  |  
|                                                  |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  

See accompanying Notes to Condensed Consolidated Financial Statements



4



---

##### Table of Contents

EXAR CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



|                                                                                     |  |                   |          |   |                  |   |          |  
|------------------------------------------------------------------------------------ |  | ----------------- | -------- | - | ---------------- | - | -------- | -
|                                                                                     |  | Nine Months Ended |         
|                                                                                     |  | December 27,2009  |          |   | December 28,2008 |  
|Cash flows from operating activities:                                                |  |                   |          |   |                  |   |          |  
|Net loss                                                                             |  | $                 | (24,800  | ) |                  | $ | (68,471  | )
|Reconciliation of net loss to net cash provided by (used in) operating activities:   |  |                   |          |   |                  |   |          |  
|Goodwill and other intangible asset impairment                                       |  |                   |         |   |                  |   | 59,676   |  
|Depreciation and amortization                                                        |  |                   | 15,644   |   |                  |   | 11,660   |  
|Stock-based compensation expense                                                     |  |                   | 4,311    |   |                  |   | 3,727    |  
|Provision for sales returns and allowances                                           |  |                   | 7,917    |   |                  |   | 6,191    |  
|Other than temporary loss on investments                                             |  |                   | 317      |   |                  |   | 1,487    |  
|Deferred income taxes                                                                |  |                   | 373      |   |                  |   |         |  
|Changes in operating assets and liabilities, net of effects of acquisitions:         |  |                   |          |   |                  |   |          |  
|Accounts receivable                                                                  |  |                   | (13,203  | ) |                  |   | 78       |  
|Inventories                                                                          |  |                   | 7,016    |   |                  |   | (3,957   | )
|Prepaid expenses and other assets                                                    |  |                   | (2,201   | ) |                  |   | (594     | )
|Accounts payable                                                                     |  |                   | 1,435    |   |                  |   | (2,016   | )
|Other accrued expenses                                                               |  |                   | 1,019    |   |                  |   | (2,042   | )
|Deferred income and allowance on sales to distributors and related party distributor |  |                   | 2,413    |   |                  |   | (1,343   | )
|Accrued compensation and related benefits                                            |  |                   | (1,633   | ) |                  |   | (400     | )
|                                                                                     |  |                   |          |   |                  |   |          |  
|Net cash provided by (used in) operating activities                                  |  |                   | (1,392   | ) |                  |   | 3,996    |  
|                                                                                     |  |                   |          |   |                  |   |          |  
|Cash flows from investing activities:                                                |  |                   |          |   |                  |   |          |  
|Purchases of property, plant and equipment and intellectual property, net            |  |                   | (4,690   | ) |                  |   | (1,969   | )
|Purchases of short-term marketable securities                                        |  |                   | (149,019 | ) |                  |   | (174,500 | )
|Proceeds from maturities of short-term marketable securities                         |  |                   | 78,675   |   |                  |   | 107,389  |  
|Proceeds from sales of short-term marketable securities                              |  |                   | 56,064   |   |                  |   | 25,875   |  
|Contributions to long-term investments                                               |  |                   | (1       | ) |                  |   | (215     | )
|Acquisition of Galazar, net of cash acquired                                         |  |                   | (4,445   | ) |                  |   |         |  
|Acquisition of Hifn, net of cash acquired                                            |  |                   | (40,345  | ) |                  |   |         |  
|                                                                                     |  |                   |          |   |                  |   |          |  
|Net cash used in investing activities                                                |  |                   | (63,761  | ) |                  |   | (43,420  | )
|                                                                                     |  |                   |          |   |                  |   |          |  
|Cash flows from financing activities:                                                |  |                   |          |   |                  |   |          |  
|Repurchase of common stock                                                           |  |                   |         |   |                  |   | (13,437  | )
|Proceeds from issuance of common stock                                               |  |                   | 367      |   |                  |   | 2,884    |  
|Repayment of lease financing obligations                                             |  |                   | (2,050   | ) |                  |   | (1,204   | )
|                                                                                     |  |                   |          |   |                  |   |          |  
|Net cash used in financing activities                                                |  |                   | (1,683   | ) |                  |   | (11,757  | )
|                                                                                     |  |                   |          |   |                  |   |          |  
|Net decrease in cash and cash equivalents                                            |  |                   | (66,836  | ) |                  |   | (51,181  | )
|Cash and cash equivalents at the beginning of period                                 |  |                   | 89,002   |   |                  |   | 122,016  |  
|                                                                                     |  |                   |          |   |                  |   |          |  
|Cash and cash equivalents at the end of period                                       |  | $                 | 22,166   |   |                  | $ | 70,835   |  
|                                                                                     |  |                   |          |   |                  |   |          |  
|Supplemental disclosure of non-cash investing and financing activities:              |  |                   |          |   |                  |   |          |  
|Issuance of common stock in connection with Hifn acquisition                         |  | $                 | 2,705    |   |                  | $ |         |  
|Property, plant and equipment acquired under capital lease                           |  |                   | 2,012    |   |                  |   | 2,571    |  

See accompanying Notes to Condensed Consolidated Financial Statements



5



---

##### Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1. ORGANIZATION AND BASIS OF PRESENTATION

Description of BusinessExar Corporation was
incorporated in California in 1971 and reincorporated in Delaware in 1991. Exar Corporation and its subsidiaries (Exar or we) is a fabless semiconductor company that designs, sub-contracts manufacturing of and sells highly
differentiated silicon, software and subsystem solutions for industrial, datacom and storage applications.

On June 17,
2009, we completed the acquisition of Galazar Networks Inc. (Galazar). Galazar, based in Ottawa, Ontario, Canada, is a fabless semiconductor and software supplier focused on carrier grade transport over telecom networks. Galazars
product portfolio addresses transport of a wide range of datacom and telecom services including Ethernet, SAN, TDM and video over SONET/SDH, PDH and OTN networks. On April 3, 2009, we completed the acquisition of hi/fn, inc. (Hifn).
Hifn is a provider of network-and storage-security and data reduction products that simplify the way major network and storage original equipment manufacturers (OEMs), as well as small-and-medium enterprises (SMEs),
efficiently and securely share, retain, optimize, transport, access and protect critical data. See Note 3 Business Combinations.

Our fiscal years consist of 52 or 53 weeks. In a 52-week year, each fiscal quarter consist of 13 weeks. The additional week in a 53-week year is added to the fourth quarter, making such quarter
consist of 14 weeks. Fiscal year 2010 and fiscal year 2009 are comprised of a 52-week period.

Basis of Presentation and
Use of Management EstimatesThe accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) regarding interim
financial reporting. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the Financial Statements and
Notes thereto included in our Annual Report on Form 10-K for the year ended March 29, 2009 as filed with the SEC. In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments, consisting
only of normal recurring adjustments, which we believe are necessary for a fair statement of Exars financial position as of December 27, 2009 and our results of operations for the three and nine months ended December 27, 2009 and
December 28, 2008, respectively. The results of operations for the three and nine months ended December 27, 2009 are not necessarily indicative of the results to be expected for any future period.

The financial statements include managements estimates and assumptions that affect the reported amounts of assets and liabilities as
of the date of the financial statements and the reported amounts of sales and expenses during the reporting periods. Actual results could differ from those estimates, and material effects on operating results and financial position may result.

Revenue Recognition

Refer to our Form 10-K for a full disclosure of our revenue accounting policies. Software has been an element of total revenue since the acquisition of Hifn on April 3, 2009. Software license revenue is recognized when a signed
agreement or other persuasive evidence of an arrangement exists, vendor-specific objective evidence exists to allocate a portion of the total fee to any undelivered elements of the arrangement, the software has been shipped or electronically
delivered, the license fee is fixed or determinable and collection of resulting receivables is reasonably assured. Returns, including exchange rights for unsold licenses, are recorded based on agreed-upon return rates or historical experience and
are deferred until the return rights expire.

Exar receives software license revenue from OEMs that sublicense our software
shipped with their products. The OEM sublicense agreements are generally valid for a term of one year and include rights to unspecified future upgrades and maintenance during the term of the agreement. License fees under these agreements are
recognized ratably over the term of the agreement. Revenues from sublicenses sold in excess of the specified volume in the original license agreement are recognized when they are reported as sold to end customers by the OEM.

To date software revenues have not been a significant part of our total revenues.

Research and Development Costs

Research and development costs consist primarily of salaries, employee benefits, depreciation, amortization, overhead, outside contractors and non-recurring engineering fees. Expenditures for research and development are charged to expense
as incurred. In accordance with Financial Accounting Standards Board (FASB) authoritative guidance for the costs of computer software to be sold, leased or otherwise marketed, certain software development costs are capitalized after
technological feasibility has been established. The period from achievement of technological feasibility, which Exar defines as the establishment of a working model,



6



---

##### Table of Contents

until the general availability of such software to customers, has been short, and therefore software development costs qualifying for capitalization have been insignificant. Accordingly, Exar has
not capitalized any software development costs as of December 27, 2009.

Starting in fiscal 2010, some of our research
and development costs are eligible for reimbursement under a contractual agreement. Amounts received under this arrangement are offset against research and development expense incurred as such research and development expenses are collected. For the
three and nine months ended December 27, 2009, Exar received $1.0 million and $3.4 million, respectively, for work performed, which was recorded as an offset to research and development expenses which are included in the Research and
development line item on the condensed consolidated statement of operations for the three and nine months ended December 27, 2009.

NOTE 2. RECENT ACCOUNTING PRONOUNCEMENTS

In September 2009, the FASBs Emerging Issues Task Force
(EITF) issued authoritative guidance addressing revenue arrangements with multiple deliverables. The guidance requires revenue to be allocated to multiple elements using relative fair value based on vendor-specific-objective-evidence,
third party evidence or estimated selling price. The residual method also becomes obsolete under this guidance. This guidance is effective for our interim reporting period ending on June 25, 2011. Early adoption is permitted. We are currently
evaluating the impact of the implementation of this guidance on our consolidated financial statements.

In September 2009,
FASBs EITF issued authoritative guidance addressing certain revenue arrangements that include software elements. This guidance states that tangible products with hardware and software components that work together to deliver the product
functionality are considered non-software products, and the accounting guidance under the revenue arrangements with multiple deliverables is to be followed. This guidance is effective for our interim reporting period ending on June 25, 2011.
Early adoption is permitted. We are currently evaluating the impact of the implementation of this guidance on our consolidated financial statements.

In June 2009, the FASB revised the authoritative guidance for the accounting for transfers of financial assets, which enhances information reported to users of financial statements by providing greater
transparency about transfers of financial assets, including securitization transactions, and where companies have continuing exposure to the risks related to transferred financial assets. Additionally, on and after the effective date, the concept of
a qualifying special-purpose entity is no longer relevant for accounting purposes and should be evaluated for consolidation by reporting entities. If the evaluation results in consolidation, the reporting entity should apply the transition guidance
provided, effective with the first annual reporting period that begins after November 15, 2009 and for interim and annual reporting periods thereafter. Early adoption is prohibited. The new guidance will apply to transfers occurring on or after
March 29, 2010 and is not expected to have a significant impact on our consolidated financial statements.

NOTE 3. BUSINESS
COMBINATIONS

We periodically evaluate strategic acquisitions that build upon or expand our existing portfolio of
intellectual property, markets, human capital and engineering talent, and seek to increase our leadership position in the areas in which we operate.

We account for each business combination by applying the acquisition method, which requires (i) identifying the acquiree; (ii) determining the acquisition date; (iii) recognizing and
measuring the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest of the acquirer in the acquiree at their acquisition date fair value; and (iv) recognizing and measuring goodwill or a gain from a bargain
purchase.

Assets acquired and liabilities assumed in a business combination that arise from contingencies are recognized at
fair value on the acquisition date if fair value can be determined during the measurement period. If fair value cannot be determined, we typically account for the acquired contingencies using existing guidance for a reasonable estimate.

To establish fair value we measure the price that would be received to sell an asset or paid to transfer a liability in an ordinary
transaction between market participants. The measurement assumes the highest and best use of the asset by the market participants that would maximize the value of the asset or the group of assets within which the asset would be used at the
measurement date, even if the intended use of the asset is different.

Goodwill is measured and recorded as the amount by
which the consideration transferred, generally at the acquisition date fair value, exceeds the acquisition date fair value of identifiable assets acquired, the liabilities assumed, and any noncontrolling interest of the acquirer in the acquiree. To
the contrary, if the acquisition date fair value of identifiable assets acquired, the liabilities assumed, and any noncontrolling interest of the acquirer in the acquiree exceeds the consideration transferred, it is considered a bargain purchase and
we would recognize the resulting gain in earnings on the acquisition date.



7



---

##### Table of Contents

In-process research and development (IPR&D) assets are considered an
indefinite-lived intangible asset and are not subject to amortization. IPR&D assets must be tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. The impairment test
consists of a comparison of the fair value of the IPR&D asset with its carrying amount. If the carrying amount of the IPR&D asset exceeds its fair value, an impairment loss must be recognized in an amount equal to that excess. After an
impairment loss is recognized, the adjusted carrying amount of the IPR&D will be its new accounting basis. Subsequent reversal of a previously recognized impairment loss is prohibited. The initial determination and subsequent evaluation for
impairment, of the IPR&D asset requires management to make significant judgments and estimates. Once the IPR&D projects have been completed or abandoned, the useful life of the IPR&D asset is determined and amortized accordingly.

Acquisition related costs, including finders fees, advisory, legal, accounting, valuation and other professional or
consulting fees are accounted for as expenses in the periods in which the costs are incurred and the services are received, with the exception that the costs to issue debt or equity securities are recognized in accordance with other applicable GAAP.

Acquisition of Galazar

On June 17, 2009, we completed the acquisition of Galazar. Galazar, based in Ottawa, Ontario, Canada, is a fabless semiconductor and software supplier focused on carrier grade transport over telecom
networks. Galazars product portfolio addresses transport of a wide range of datacom and telecom services including Ethernet, SAN, TDM and video over SONET/SDH, PDH and OTN networks. Galazars results of operations and estimated fair value
of assets acquired and liabilities assumed were included in our condensed consolidated financial statements beginning June 18, 2009.

Consideration

We expected to pay approximately $4.95 million in cash for
Galazar, representing the fair value of total consideration transferred. This amount included approximately $1.0 million contingent consideration that, for the purposes of valuation, was assigned a 95% probability or a fair value of $0.95 million.
This payment was contingent on Galazar achieving a project milestone within a twelve-month period following the close of the transaction. This milestone was met during the third fiscal quarter and $1.0 million was paid in cash. The additional
$50,000 was expensed and included in the Research and development line item on the condensed consolidated statement of operations for the three and nine months ended December 27, 2009

Acquisition-Related Costs

Acquisition-related costs, or deal costs, which are included in the Selling, general and administrative line item on the condensed consolidated statement of operations for the nine months
ended December 27, 2009, were $617,000. No acquisition-related costs were incurred during the three months ended December 27, 2009.

Purchase Price Allocation

The allocation of the purchase price to
Galazars tangible and identifiable intangible assets acquired and liabilities assumed was based on their estimated fair values at the date of acquisition. We will recognize additional assets or liabilities if new information is obtained about
facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets and liabilities as of that date. The measurement period shall not exceed one year from the acquisition date.
Further, any associated restructuring activities will be expensed in future periods. Subsequent to the acquisition, we recorded severance cost of $100,000 and $234,000 for the three and nine months ended December 27, 2009, respectively.

The excess of the purchase price over the tangible and identifiable intangible assets acquired and liabilities assumed has
been allocated to goodwill. The $372,000 in goodwill resulted primarily from our expected synergies from the integration of Galazars technology into our product offerings. Goodwill is not deductible for tax purposes. We have up to twelve
months from the closing date of the acquisition to adjust pre-acquisition contingencies, if any.



8



---

##### Table of Contents

The fair value allocated to each of the major classes of tangible and identifiable
intangible assets acquired and liabilities assumed of Galazar was as follows (in thousands):



|                                              |  |                   |       |  
|--------------------------------------------- |  | ----------------- | ----- | -
|                                              |  | As ofJune 17,2009 |      
|Identifiable tangible assets                  |  |                   |       |  
|Cash and cash equivalents                     |  | $                 | 506   |  
|Accounts receivable                           |  |                   | 120   |  
|Inventories                                   |  |                   | 692   |  
|Other current assets                          |  |                   | 97    |  
|Property, plant and equipment                 |  |                   | 223   |  
|Other assets                                  |  |                   | 27    |  
|Accounts payable and accruals                 |  |                   | (93   | )
|Accrued compensation and related benefits     |  |                   | (230  | )
|Long-term obligations and other               |  |                   | (224  | )
|                                              |  |                   |       |  
|Total identifiable tangible assets, net       |  |                   | 1,118 |  
|Identifiable intangible assets                |  |                   | 3,460 |  
|                                              |  |                   |       |  
|Total identifiable assets, net                |  |                   | 4,578 |  
|Goodwill                                      |  |                   | 372   |  
|                                              |  |                   |       |  
|Fair value of total consideration transferred |  | $                 | 4,950 |  
|                                              |  |                   |       |  

There were no adjustments, in the three months ended December 27, 2009, to the
fair value allocated to each of the major classes of tangible and identifiable intangible assets acquired and liabilities assumed on June 17, 2009 in the Galazar acquisition.

Identifiable Intangible Assets

The following table sets forth the components of the identifiable intangible assets acquired in the Galazar acquisition, which are being amortized over their estimated useful lives, with a maximum
amortization period of six years, on a straight-line basis with no residual value:



|                                              |  |                |       |             |    
|--------------------------------------------- |  | -------------- | ----- | ----------- | ---
|                                              |  | Fair Value     |       | Useful Life
|                                              |  | (in thousands) |       | (in years) 
|Existing technologies                         |  | $              | 2,100 |             | 6.0
|Patents/Core technology                       |  |                | 400   |             | 6.0
|In-process research and development           |  |                | 300   |             |   
|Customer relationships                        |  |                | 500   |             | 6.0
|Order backlog                                 |  |                | 60    |             | 0.3
|Tradenames/Trademarks                         |  |                | 100   |             | 3.0
|                                              |  |                |       |             |    
|Total acquired identifiable intangible assets |  | $              | 3,460 |             |    
|                                              |  |                |       |             |    

We allocated the purchase price using established valuation techniques.

InventoriesThe value allocated to inventories reflects the estimated fair value of the acquired inventory based on the
expected sales price of the inventory, less reasonable selling margin.

Property, plant and equipment The basis
used for our analysis is the fair value in continued use, which is expressed in terms of the price a willing and informed buyer would pay contemplating continued use of the assets in place for the purpose for which they were designed, engineered,
installed, fabricated and erected.

Intangible assets The fair value of existing technology, patents/core
technology, IPR&D, customer relationships, order backlog and tradenames/trademarks were determined using the income approach, which discounted expected future cash flows to present value, taking into account multiple factors including, but not
limited to, the stage of completion, estimated costs to complete, utilization of patents and core technology, the risks related to successful completion, and the markets served. The cash flows were discounted at rates ranging from 5% to 35%. The
discount rate used to value the existing intangible assets was 28%.

Acquired In-Process Research and Development
The IPR&D project underway at Galazar at the acquisition date relates to the MXP2 product and to date has incurred approximately $2.3 million in expense. The total research and development expense expected to be incurred to complete
the project is estimated at $7.2 million, based on the project development timeline and resource requirements, and is scheduled for completion by April 2011. The percentage of completion for the project was estimated at 70% at the acquisition date.



9



---

##### Table of Contents

Acquisition of Hifn

On April 3, 2009, we completed the acquisition of all of the outstanding shares of Hifn. Hifn is a provider of network-and storage-security and data reduction products that simplify the way major
network and storage OEMs, as well as SMEs, efficiently and securely share, retain, access and protect critical data. Hifns results of operations and estimated fair value of assets acquired and liabilities assumed were included in our condensed
consolidated financial statements beginning April 4, 2009.

Consideration

The following table summarizes the consideration paid for Hifn, representing the fair value of total consideration transferred (in
thousands):



|                         |  |         |       
|------------------------ |  | ------- | ------
|                         |  | Amounts
|Cash                     |  | $       | 56,825
|Equity instruments       |  |         | 2,784 
|                         |  |         |       
|Total consideration paid |  | $       | 59,609
|                         |  |         |       

The $2.8 million estimated fair value for equity instruments represented
approximately 429,600 shares of Exars common stock, valued at $6.48 per share, the closing price reported on the NASDAQ Global Market on April 3, 2009 (the acquisition date).

Acquisition-Related Costs

Acquisition-related costs, or deal costs, which are included in the Selling, general and administrative line item on the condensed consolidated statement of operations for the fiscal year
ended March 29, 2009 and the nine months ended December 27, 2009, were $778,000 and $1.5 million, respectively.

Purchase Price Allocation

The allocation of the purchase price to Hifns tangible and identifiable
intangible assets acquired and liabilities assumed was based on their estimated fair values at the date of acquisition. We will recognize additional assets or liabilities if new information is obtained about facts and circumstances that existed as
of the acquisition date that, if known, would have resulted in the recognition of those assets and liabilities as of that date. The measurement period shall not exceed one year from the acquisition date. Further, any associated restructuring
activities will be expensed in future periods. Subsequent to the acquisition, we recorded $180,000 and $983,000 in restructuring expenses for the three and nine months ended December 27, 2009, respectively, relating to severance and a building
lease obligation in Los Gatos, California.

The excess of the purchase price over the tangible and identifiable intangible
assets acquired and liabilities assumed has been allocated to goodwill. The $2.2 million in goodwill resulted primarily from our expected future product sales synergies from combining Hifns products with our product offerings. Goodwill is not
deductible for tax purposes. We have up to twelve months from the closing date of the acquisition to adjust pre-acquisition contingencies, if any.



10



---

##### Table of Contents

The fair value allocated to each of the major classes of tangible and identifiable
intangible assets acquired and liabilities assumed on April 3, 2009 in the Hifn acquisition was as follows (in thousands):



|                                               |  |                   |        |  
|---------------------------------------------- |  | ----------------- | ------ | -
|                                               |  | As ofApril 3,2009 |       
|Identifiable tangible assets                   |  |                   |        |  
|Cash, cash equivalents                         |  | $                 | 16,468 |  
|Short-term marketable securities               |  |                   | 14,133 |  
|Accounts receivable                            |  |                   | 2,982  |  
|Inventories                                    |  |                   | 4,269  |  
|Other current assets                           |  |                   | 1,683  |  
|Property, plant and equipment                  |  |                   | 2,013  |  
|Other assets                                   |  |                   | 1,721  |  
|Accounts payable and accruals                  |  |                   | (586   | )
|Accrued compensation and related benefits      |  |                   | (1,860 | )
|Other current liabilities                      |  |                   | (2,963 | )
|                                               |  |                   |        |  
|Total identifiable tangible assets, net        |  |                   | 37,860 |  
|Identifiable intangible assets                 |  |                   | 19,500 |  
|                                               |  |                   |        |  
|Total identifiable assets, net                 |  |                   | 57,360 |  
|Goodwill                                       |  |                   | 2,249  |  
|                                               |  |                   |        |  
|Fair value of total considerations transferred |  | $                 | 59,609 |  
|                                               |  |                   |        |  

There were no adjustments, in the three months ended December 27, 2009, to the
fair value allocated to each of the major classes of tangible and identifiable intangible assets acquired and liabilities assumed on April 3, 2009 in the Hifn acquisition.

Identifiable Intangible Assets

The following table sets forth the components of the identifiable intangible assets acquired in the Hifn acquisition, which are being amortized over their estimated useful lives on a straight-line basis
with no residual value:



|                                                |  |                |        |             |    
|----------------------------------------------- |  | -------------- | ------ | ----------- | ---
|                                                |  | Fair Value     |        | Useful Life
|                                                |  | (in thousands) |        | (in years) 
|Existing technologies                           |  | $              | 9,000  |             | 5.0
|Patents/Core technology                         |  |                | 1,500  |             | 5.0
|In-process research and development             |  |                | 1,600  |             |   
|Research and development reimbursement contract |  |                | 4,500  |             | 2.0
|Customer relationships                          |  |                | 1,300  |             | 7.0
|Order backlog                                   |  |                | 900    |             | 0.5
|Tradenames/Trademarks                           |  |                | 700    |             | 3.0
|                                                |  |                |        |             |    
|Total acquired identifiable intangible assets   |  | $              | 19,500 |             |    
|                                                |  |                |        |             |    

We allocated the purchase price using established valuation techniques.

InventoriesInventories acquired in connection with the Hifn acquisition were finished goods. The value allocated to
inventories reflects the estimated fair value of the acquired inventory based on the expected sales price of the inventory, less reasonable selling margin.

Property, plant and equipmentThe basis used for our analysis is the fair value in continued use, which is expressed in terms of the price a willing and informed buyer would pay contemplating
continued use as part of the assets in place for the purpose for which they were designed, engineered, installed, fabricated and erected.

Intangible assetsThe fair value of existing technology, patents/core technology, in-process research and development, research and development reimbursement contract, customer relationships,
order backlog and tradenames/trademarks were determined using the income approach, which discounted expected future cash flows to present value, taking into account multiple factors including, but not limited to, the stage of completion, estimated
costs to complete, utilization of patents and core technology, the risks related to successful completion, and the markets served. The cash flows were discounted at rates ranging from 5% to 30%. The discount rate used to value the existing
intangible assets was 14%.



11



---

##### Table of Contents

Acquired In-Process Research and DevelopmentThe IPR&D projects underway at
Hifn at the acquisition date were in the security processors and flow through product families, each consisting of one project, and to date have incurred approximately $2.6 million and $1.1 million in costs, respectively. The percentage of
completion for these projects, at the date of acquisition, was 90% and 30%, respectively. The total research and development expenditures expected to be incurred to complete the security processors and flow through projects are approximately $2.1
million and $0.7 million, respectively, based on project development timelines and resource requirements. IPR&D projects for security processors and flow through are scheduled for completion by April 2010 and January 2010, respectively.

Pro Forma Financial Information for Hifn and Galazar

The following unaudited pro forma financial information is based on the respective historical financial statements of Exar, Hifn and Galazar. The unaudited pro forma financial information reflects the
results of operations as if the acquisition of Hifn and Galazar occurred at the beginning of each period and includes the amortization of the resulting identifiable acquired intangible assets and the effects of the estimated write-up of Hifn and
Galazar inventory to fair value on cost of goods sold. These unaudited pro forma financial information adjustments reflect their related tax effects. The unaudited pro forma financial data is provided for illustrative purposes only and is not
necessarily indicative of the results of operations for future periods or what actually would have been realized had Exar, Hifn and Galazar been a consolidated entity during the periods presented.

The amounts of Hifns and Galazars revenue included in Exars condensed consolidated statements of operations for the three
and nine months ended December 27, 2009, and the revenue and earnings of the combined entity had the acquisition date been March 30, 2008, were as follows (in thousands except for per share data):



|                                                            |  |             |         |                 |   |         |                                     |  |   |       |  
|----------------------------------------------------------- |  | ----------- | ------- | --------------- | - | ------- | ----------------------------------- |  | - | ----- | -
|                                                            |  | Revenue (1) |         | Net Loss (1)(2) |   |         | Loss Per SharesBasic andDiluted (2) | 
|Actual included in this quarter                             |  | $           | 7,294   |                 |   | N/A     |                                     |  |   | N/A   |  
|                                                            |  |             |        
|Actual included for the nine months ended December 27, 2009 |  |             | 20,404  |                 |   | N/A     |                                     |  |   | N/A   |  
|                                                            |  |             |        
|Supplement pro forma for the nine months ended              |  |             |         |                 |   |         |                                     |  |   |       |  
|December 27, 2009                                           |  |             | 97,075  |                 | $ | (27,439 | )                                   |  | $ | (0.63 | )
|December 28, 2008                                           |  |             | 120,603 |                 |   | (84,256 | )                                   |  |   | (1.97 | )



|(1) | Pro forma information for the nine months ended December 27, 2009 and December 28, 2008 includes Hifns and Galazars financial results for the
periods April 1, 2009 through December 27, 2009 and April 1, 2008 through December 31, 2008, respectively.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(2) | As a result of the Hifn and Galazar integration it was deemed impractical to determine net loss and earnings per share for the two entities.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------

NOTE 4. CASH, CASH EQUIVALENTS AND SHORT-TERM MARKETABLE SECURITIES

Fair Value of Financial Instruments

Fair value is defined as the exchange
price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques
used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. GAAP describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last
unobservable, that may be used to measure fair value which are the following:



|        |  |   |  |                                                                                                                                                                                                                                                                                                                                        
|------- |  | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Level 1 |  |  |  | Quoted prices in active markets for identical assets or liabilities.                                                                                                                                                                                                                                                                   
|        |  |  
|Level 2 |  |  |  | Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active;
or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
|        |  |  
|Level 3 |  |  |  | Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.                                                                                                                                                                                        



12



---

##### Table of Contents

Our investment assets, measured at fair value on a recurring basis, as of December 27,
2009 were as follows (in thousands):



|                                                 |  |         |        |         |   |         |  |       |   |  |   |        
|------------------------------------------------ |  | ------- | ------ | ------- | - | ------- |  | ----- | - |  | - | -------
|                                                 |  | Level 1 |        | Level 2 |   | Level 3 |  | Total
|Assets:                                          |  |         |        |         |   |         |  |       |   |  |   |        
|Money market funds                               |  | $       | 19,846 |         | $ |        |  | $     |  |  | $ | 19,846 
|U.S. Treasury securities                         |  |         | 10,424 |         |   |        |  |       |  |  |   | 10,424 
|Asset-backed securities                          |  |         |       |         |   | 17,713  |  |       |  |  |   | 17,713 
|Mortgage-backed securities                       |  |         |       |         |   | 55,016  |  |       |  |  |   | 55,016 
|Other fixed income available-for-sale securities |  |         |       |         |   | 112,937 |  |       |  |  |   | 112,937
|                                                 |  |         |        |         |   |         |  |       |   |  |   |        
|Total financial instruments owned                |  | $       | 30,270 |         | $ | 185,666 |  | $     |  |  | $ | 215,936
|                                                 |  |         |        |         |   |         |  |       |   |  |   |        

Our investment assets, measured at fair value on a recurring basis, as of
March 29, 2009 were as follows (in thousands):



|                                                 |  |         |        |         |   |         |  |       |   |  |   |        
|------------------------------------------------ |  | ------- | ------ | ------- | - | ------- |  | ----- | - |  | - | -------
|                                                 |  | Level 1 |        | Level 2 |   | Level 3 |  | Total
|Assets:                                          |  |         |        |         |   |         |  |       |   |  |   |        
|Money market funds                               |  | $       | 26,332 |         | $ |        |  | $     |  |  | $ | 26,332 
|U.S. Treasury securities                         |  |         | 4,327  |         |   |        |  |       |  |  |   | 4,327  
|Asset-backed securities                          |  |         |       |         |   | 8,559   |  |       |  |  |   | 8,559  
|Mortgage-backed securities                       |  |         |       |         |   | 26,464  |  |       |  |  |   | 26,464 
|Other fixed income available-for-sale securities |  |         |       |         |   | 188,952 |  |       |  |  |   | 188,952
|                                                 |  |         |        |         |   |         |  |       |   |  |   |        
|Total financial instruments owned                |  | $       | 30,659 |         | $ | 223,975 |  | $     |  |  | $ | 254,634
|                                                 |  |         |        |         |   |         |  |       |   |  |   |        

Our cash, cash equivalents and short-term marketable securities as of
December 27, 2009 and March 29, 2009 were as follows (in thousands):



|                                       |  |                  |         |               |   |        
|-------------------------------------- |  | ---------------- | ------- | ------------- | - | -------
|                                       |  | December 27,2009 |         | March 29,2009
|Cash and cash equivalents              |  |                  |         |               |   |        
|Cash in financial institutions         |  | $                | 2,320   |               | $ | 1,709  
|                                       |  |                  |         |               |   |        
|Cash equivalents                       |  |                  |         |               |   |        
|Money market funds                     |  |                  | 19,846  |               |   | 26,332 
|U.S. government and agency securities  |  |                  |        |               |   | 60,961 
|                                       |  |                  |         |               |   |        
|Total cash equivalents                 |  |                  | 19,846  |               |   | 87,293 
|                                       |  |                  |         |               |   |        
|Total cash and cash equivalents        |  | $                | 22,166  |               | $ | 89,002 
|                                       |  |                  |         |               |   |        
|Short-term marketable securities       |  |                  |         |               |   |        
|U.S. government and agency securities  |  | $                | 60,840  |               | $ | 104,130
|Corporate bonds and commercial paper   |  |                  | 62,521  |               |   | 28,188 
|Asset-backed securities                |  |                  | 17,713  |               |   | 8,559  
|Mortgage-backed securities             |  |                  | 55,016  |               |   | 26,464 
|                                       |  |                  |         |               |   |        
|Total short-term marketable securities |  | $                | 196,090 |               | $ | 167,341
|                                       |  |                  |         |               |   |        

Our marketable securities include municipal securities, commercial paper, asset and
mortgage-backed securities, corporate bonds and government securities. We classify investments as available-for-sale at the time of purchase and re-evaluate such designation as of each balance sheet date. We amortize premiums and accrete discounts
to interest income over the life of the investment. Our available-for-sale securities are classified as cash equivalents if the maturity from the date of purchase is 90 days or less and as short-term marketable securities for those with maturities,
from the date of purchase, in excess of 90 days which we intend to sell as necessary to meet our liquidity requirements.

All
marketable securities are reported at fair value based on the estimated or quoted market prices as of each balance sheet date, with unrealized gains or losses, net of tax effect, recorded in accumulated other comprehensive income within
stockholders equity except those unrealized losses that are deemed to be other than temporary which are reflected in the Other income and expense, net section in the condensed consolidated statements of operations.



13



---

##### Table of Contents

Realized gains or losses on the sale of marketable securities are determined by the specific
identification method and are reflected in the Interest income and other, net line item of the condensed consolidated statements of operation.

Net realized losses on marketable securities for three months ended December 27, 2009 were $58,000. Net realized gains on marketable securities for the three months ended December 28, 2008 were
$27,000. Net realized gains on marketable securities for the nine months ended December 27, 2009 was $100,000. Net realized loss on marketable securities for the nine months ended December 28, 2008 was $245,000.

The following table summarizes our investments in cash equivalents and marketable securities as of December 27, 2009 and March 29,
2009 (in thousands):



|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        
|------------------------------------- |  | ----------------- | ----------- | ---------- | ------------ | ----- | ---------- | - | ---- | - |  | - | -------
|                                      |  | December 27, 2009
|                                      |  | AmortizedCost     |             | Unrealized |              |       | Fair Value
|                                      |  |                   | Gross Gains |            | Gross Losses |       |           
|Money market funds                    |  | $                 | 19,846      |            | $            |      |            | $ |     |   |  | $ | 19,846 
|Corporate bonds and commercial paper  |  |                   | 61,706      |            |              | 859   |            |   | (44  | ) |  |   | 62,521 
|U.S. government and agency securities |  |                   | 59,729      |            |              | 1,132 |            |   | (21  | ) |  |   | 60,840 
|Asset and mortgage-backed securities  |  |                   | 72,236      |            |              | 576   |            |   | (83  | ) |  |   | 72,729 
|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        
|Total investment                      |  | $                 | 213,517     |            | $            | 2,567 |            | $ | (148 | ) |  | $ | 215,936
|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        
|                                      | 
|                                      |  | March 29, 2009   
|                                      |  | AmortizedCost     |             | Unrealized |              |       | Fair Value
|                                      |  |                   | Gross Gains |            | Gross Losses |       |           
|Money market funds                    |  | $                 | 26,332      |            | $            |      |            | $ |     |   |  | $ | 26,332 
|Corporate bonds and commercial paper  |  |                   | 28,169      |            |              | 160   |            |   | (141 | ) |  |   | 28,188 
|U.S. government and agency securities |  |                   | 163,750     |            |              | 1,379 |            |   | (38  | ) |  |   | 165,091
|Asset and mortgage-backed securities  |  |                   | 35,070      |            |              | 317   |            |   | (364 | ) |  |   | 35,023 
|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        
|Total investment                      |  | $                 | 253,321     |            | $            | 1,856 |            | $ | (543 | ) |  | $ | 254,634
|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        

As of December 27, 2009, asset-backed and mortgage-backed securities accounted
for 8% and 25%, respectively, of our total investments in marketable securities of $215.9 million. The asset-back securities are comprised primarily of premium tranches of auto loans and credit card receivables, while our mortgage-backed securities
are primarily from federal agencies. We do not own auction rate securities nor do we own securities that are classified as sub-prime. As of the date of this Form 10-Q, we have sufficient liquidity and do not intend to sell these securities nor
realize any significant losses in the short term. As of December 27, 2009, the net unrealized gain of our asset-backed and mortgage-backed securities totaled $493,000.

Management determines the appropriate classification of cash equivalents or short-term marketable securities at the time of purchase and
reevaluates such classification as of each balance sheet date. The investments are adjusted for amortization of premiums and discounts to maturity and such amortization is included in the Interest income and other, net line item in the
condensed consolidated statement of operations. Cash equivalents and short-term marketable securities are reported at fair value with the related unrealized gains and losses included in the Accumulated other comprehensive income line
item in the condensed consolidated balance sheets. As of December 27, 2009, there was $1.5 million of net unrealized gains net of tax from our Level 1 and Level 2 investments.

We periodically review our investments in unrealized loss positions for other-than-temporary impairments. This evaluation includes, but is
not limited to, significant quantitative and qualitative assessments and estimates regarding credit ratings, collateralized support, the length of time and significance of a securitys loss position, our intent to not sell the security, and
whether it is more likely than not that we will not have to sell the security before recovery of its cost basis. Realized gains and losses and declines in value of our investments judged to be other-than-temporary are reported in the
Impairment charges on investments line item in the condensed consolidated statements of operations. In September 2008, Lehman Brothers Holdings Inc. (Lehman) filed a petition under Chapter 11 of the U.S. Bankruptcy Code
with the U.S. Bankruptcy Court for the Southern District of New York. As a result of Lehmans bankruptcy filing, we recorded an other-than-temporary impairment charge of $0.6 million during our fiscal year ended March 29, 2009.

In the second quarter of fiscal 2010, an investment in GSAA Home Equity with a cost of $425,000 was downgraded from an AAA rating to a
CCC rating. As a result of the reduction in the rating, quantitative analysis showing an increase in the default rate and decrease in prepayment rate of the investment, we recorded an other-than-temporary impairment charge of $91,000 during the
second quarter of fiscal 2010.



14



---

##### Table of Contents

The amortized cost and estimated fair value of cash equivalents and marketable securities
classified as available-for-sale at December 27, 2009 and March 29, 2009 by expected maturity were as follows (in thousands):



|                    |  |                   |         |                |   |               |  |            |         |  |   |        
|------------------- |  | ----------------- | ------- | -------------- | - | ------------- |  | ---------- | ------- |  | - | -------
|                    |  | December 27, 2009 |         | March 29, 2009
|                    |  | AmortizedCost     |         | Fair Value     |   | AmortizedCost |  | Fair Value
|Less than 1 year    |  | $                 | 99,191  |                | $ | 99,969        |  | $          | 183,724 |  | $ | 183,742
|Due in 1 to 5 years |  |                   | 114,326 |                |   | 115,967       |  |            | 69,597  |  |   | 70,892 
|                    |  |                   |         |                |   |               |  |            |         |  |   |        
|Total               |  | $                 | 213,517 |                | $ | 215,936       |  | $          | 253,321 |  | $ | 254,634
|                    |  |                   |         |                |   |               |  |            |         |  |   |        

The following table summarizes the gross unrealized losses and fair values of our
investments in an unrealized loss position as of December 27, 2009 and March 29, 2009, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position (in thousands):



|                                      |  |                     |        |                       |                      |      |            |       |                       |       |  |            |      |                       |  |   |        |  |   |      |  
|------------------------------------- |  | ------------------- | ------ | --------------------- | -------------------- | ---- | ---------- | ----- | --------------------- | ----- |  | ---------- | ---- | --------------------- |  | - | ------ |  | - | ---- | -
|                                      |  | December 27, 2009   |       
|                                      |  | Less than 12 months |        |                       | 12 months or greater |      |            | Total |                      
|                                      |  | Fair Value          |        | GrossUnrealizedLosses |                      |      | Fair Value |       | GrossUnrealizedLosses |       |  | Fair Value |      | GrossUnrealizedLosses | 
|Corporate bonds and commercial paper  |  | $                   | 11,085 |                       | $                    | (51  | )          |       | $                     |      |  | $          |     |                       |  | $ | 11,085 |  | $ | (51  | )
|U.S. government and agency securities |  |                     | 1,993  |                       |                      | (14  | )          |       |                       |      |  |            |     |                       |  |   | 1,993  |  |   | (14  | )
|Asset and mortgage-backed securities  |  |                     | 14,107 |                       |                      | (38  | )          |       |                       | 468   |  |            | (45  | )                     |  |   | 14,575 |  |   | (83  | )
|                                      |  |                     |        |                       |                      |      |            |       |                       |       |  |            |      |                       |  |   |        |  |   |      |  
|Total                                 |  | $                   | 27,185 |                       | $                    | (103 | )          |       | $                     | 468   |  | $          | (45  | )                     |  | $ | 27,653 |  | $ | (148 | )
|                                      |  |                     |        |                       |                      |      |            |       |                       |       |  |            |      |                       |  |   |        |  |   |      |  
|                                      | 
|                                      |  | March 29, 2009      |       
|                                      |  | Less than 12 months |        |                       | 12 months or greater |      |            | Total |                      
|                                      |  | Fair Value          |        | GrossUnrealizedLosses |                      |      | Fair Value |       | GrossUnrealizedLosses |       |  | Fair Value |      | GrossUnrealizedLosses | 
|Corporate bonds and commercial paper  |  | $                   | 10,144 |                       | $                    | (106 | )          |       | $                     | 3,614 |  | $          | (35  | )                     |  | $ | 13,758 |  | $ | (141 | )
|U.S. government and agency securities |  |                     | 62,128 |                       |                      | (38  | )          |       |                       |      |  |            |     |                       |  |   | 62,128 |  |   | (38  | )
|Asset and mortgage-backed securities  |  |                     | 8,913  |                       |                      | (50  | )          |       |                       | 887   |  |            | (314 | )                     |  |   | 9,800  |  |   | (364 | )
|                                      |  |                     |        |                       |                      |      |            |       |                       |       |  |            |      |                       |  |   |        |  |   |      |  
|Total                                 |  | $                   | 81,185 |                       | $                    | (194 | )          |       | $                     | 4,501 |  | $          | (349 | )                     |  | $ | 85,686 |  | $ | (543 | )
|                                      |  |                     |        |                       |                      |      |            |       |                       |       |  |            |      |                       |  |   |        |  |   |      |  

NOTE 5. GOODWILL AND INTANGIBLE ASSETS

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. We evaluate goodwill for impairment on an annual basis or whenever events
and changes in circumstances suggest that the carrying amount may not be recoverable. We conduct our annual impairment analysis in the fourth quarter of each fiscal year. Impairment of goodwill is tested at the reporting unit level by comparing the
reporting units carrying amount, including goodwill, to the fair value of the reporting unit. The fair values of the reporting units are estimated using a combination of the income approach that uses discounted cash flows and the market
approach that utilizes comparable companies data. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered impaired and a second step is performed to measure the amount of impairment loss. Because we have one
reporting unit, we utilize an entity-wide approach to assess goodwill for impairment.

During the third quarter of fiscal
2010, no events or changes in circumstances suggested that the carrying amount for goodwill may not be recoverable and therefore we did not perform an interim goodwill impairment analysis. We recorded a goodwill impairment charge totaling $46.2
million and $128.5 million in fiscal years 2009 and 2008, respectively, which reduced the carrying amount to zero prior to the additions of Hifn and Galazar during the first quarter of fiscal year 2010.



15



---

##### Table of Contents

The changes in the carrying amount of goodwill for the nine months ended December 27,
2009 were as follows (in thousands):



|                                                             |  |        |      
|------------------------------------------------------------ |  | ------ | -----
|                                                             |  | Amount
|Balance as of March 29, 2009                                 |  | $      |     
|Goodwill addition in connection with the Hifn acquisition    |  |        | 2,249
|Goodwill addition in connection with the Galazar acquisition |  |        | 372  
|                                                             |  |        |      
|Balance as of December 27, 2009                              |  | $      | 2,621
|                                                             |  |        |      

Intangible Assets

Our purchased intangible assets at December 27, 2009 and March 29, 2009 were as follows (in thousands):



|                                                |  |                   |        |                         |   |         |                   |  |                |        |                         |   |        |                   |   |         |   |  |   |      
|----------------------------------------------- |  | ----------------- | ------ | ----------------------- | - | ------- | ----------------- |  | -------------- | ------ | ----------------------- | - | ------ | ----------------- | - | ------- | - |  | - | -----
|                                                |  | December 27, 2009 |        | March 29, 2009         
|                                                |  | CarryingAmount    |        | AccumulatedAmortization |   |         | NetCarryingAmount |  | CarryingAmount |        | AccumulatedAmortization |   |        | NetCarryingAmount
|Existing technology                             |  | $                 | 29,521 |                         | $ | (14,288 | )                 |  | $              | 15,233 |                         | $ | 16,870 |                   | $ | (10,798 | ) |  | $ | 6,072
|Patents/Core technology                         |  |                   | 3,592  |                         |   | (1,553  | )                 |  |                | 2,039  |                         |   | 1,692  |                   |   | (1,189  | ) |  |   | 503  
|In-process research and development             |  |                   | 1,900  |                         |   |        |                   |  |                | 1,900  |                         |   |       |                   |   |        |   |  |   |     
|Research and development reimbursement contract |  |                   | 4,500  |                         |   | (1,641  | )                 |  |                | 2,859  |                         |   |       |                   |   |        |   |  |   |     
|Customer backlog                                |  |                   | 1,300  |                         |   | (1,300  | )                 |  |                |       |                         |   | 340    |                   |   | (340    | ) |  |   |     
|Distributor relationships                       |  |                   | 1,264  |                         |   | (892    | )                 |  |                | 372    |                         |   | 1,264  |                   |   | (817    | ) |  |   | 447  
|Customer relationships                          |  |                   | 2,570  |                         |   | (682    | )                 |  |                | 1,888  |                         |   | 770    |                   |   | (460    | ) |  |   | 310  
|Tradenames/Trademarks                           |  |                   | 977    |                         |   | (351    | )                 |  |                | 626    |                         |   | 177    |                   |   | (150    | ) |  |   | 27   
|                                                |  |                   |        |                         |   |         |                   |  |                |        |                         |   |        |                   |   |         |   |  |   |      
|Total                                           |  | $                 | 45,624 |                         | $ | (20,707 | )                 |  | $              | 24,917 |                         | $ | 21,113 |                   | $ | (13,754 | ) |  | $ | 7,359
|                                                |  |                   |        |                         |   |         |                   |  |                |        |                         |   |        |                   |   |         |   |  |   |      

The IPR&D assets are considered indefinite-lived intangible assets and are not
subject to amortization. IPR&D must be tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. The impairment test consists of a comparison of the fair value of each
IPR&D asset with its carrying amount. If the carrying amount of the IPR&D assets exceed their fair value, an impairment loss must be recognized in an amount equal to that excess. After an impairment loss is recognized, the adjusted carrying
amount of the IPR&D assets will be their new accounting basis. Subsequent reversal of a previously recognized impairment loss is prohibited. The initial determination and subsequent evaluation for impairment of the IPR&D asset requires
management to make significant judgments and estimates. Once the IPR&D activities have been completed or abandoned, the useful life of the IPR&D assets are reviewed for appropriateness.

As of December 27, 2009 there were no indicators that required us to perform an intangible assets impairment review.

The aggregate amortization expenses for our purchased intangible assets for periods presented below were as follows:



|                                                 |  |                       |                  |                    |                  |                   |                  |       |                  |   |       |  |   |      
|------------------------------------------------ |  | --------------------- | ---------------- | ------------------ | ---------------- | ----------------- | ---------------- | ----- | ---------------- | - | ----- |  | - | -----
|                                                 |  | WeightedAverage Lives |                  | Three Months Ended |                  | Nine Months Ended
|                                                 |  |                       | December 27,2009 |                    | December 28,2008 |                   | December 27,2009 |       | December 28,2008
|                                                 |  | (in months)           |                  | (in thousands)    
|Existing technology                              |  | 66                    |                  | $                  | 1,216            |                   | $                | 1,061 |                  | $ | 3,490 |  | $ | 3,628
|Patents/Core technology                          |  | 60                    |                  |                    | 129              |                   |                  | 102   |                  |   | 364   |  |   | 371  
|Research and development reimbursement contracts |  | 24                    |                  |                    | 563              |                   |                  |      |                  |   | 1,641 |  |   |     
|Customer backlog                                 |  | 6                     |                  |                    | 42               |                   |                  |      |                  |   | 960   |  |   |     
|Distributor relationships                        |  | 72                    |                  |                    | 25               |                   |                  | 70    |                  |   | 75    |  |   | 255  
|Customer relationships                           |  | 83                    |                  |                    | 82               |                   |                  | 40    |                  |   | 222   |  |   | 144  
|Tradenames/Trademarks                            |  | 36                    |                  |                    | 71               |                   |                  | 13    |                  |   | 201   |  |   | 47   
|                                                 |  |                       |                  |                    |                  |                   |                  |       |                  |   |       |  |   |      
|Total                                            |  |                       |                  | $                  | 2,128            |                   | $                | 1,286 |                  | $ | 6,953 |  | $ | 4,445
|                                                 |  |                       |                  |                    |                  |                   |                  |       |                  |   |       |  |   |      



16



---

##### Table of Contents

The estimated future amortization expenses, by fiscal year, for our purchased intangible
assets are summarized below (in thousands):



|                             |  |        |       
|---------------------------- |  | ------ | ------
|Fiscal Year                  |  | Amount
|2010 (3 months remaining)    |  | $      | 2,257 
|2011                         |  |        | 8,440 
|2012                         |  |        | 4,843 
|2013                         |  |        | 4,185 
|2014                         |  |        | 3,597 
|2015 and thereafter          |  |        | 1,595 
|                             |  |        |       
|Total estimated amortization |  | $      | 24,917
|                             |  |        |       

NOTE 6. LONG-TERM INVESTMENTS

Our long-term investment consists of our investment in Skypoint Telecom Fund II (US), L.P. (Skypoint Fund). Skypoint Fund is a
venture capital fund that invested primarily in private companies in the telecommunications and/or networking industry. We account for this non-marketable equity investment under the cost method. We have periodically reviewed and determined whether
the investment is other-than-temporarily impaired, in which case the investment is written down to its impaired value.

Our
investment in TechFarm Ventures L.P. (TechFarm Fund), to which we contributed $4.0 million in capital since we became a limited partner in May 2001, had a carrying amount of zero as of March 29, 2009, reflecting the net of the
capital contribution and the cumulative impairment charges.

As of December 27, 2009 and March 29, 2009, our
long-term investments balance, which is included in the Other non-current assets line item on the condensed consolidated balance sheets were as follows (in thousands):



|                      |  |                  |       |               |   |      
|--------------------- |  | ---------------- | ----- | ------------- | - | -----
|Long-term investments |  | December 27,2009 |       | March 29,2009
|Skypoint Fund         |  | $                | 1,435 |               | $ | 1,660
|                      |  |                  |       |               |   |      

We have made $4.5 million in capital contributions to Skypoint Fund since we became a
limited partner in July 2001. We contributed $36,500 to the fund during the nine months ended December 27, 2009. As of December 27, 2009, we have a remaining obligation of $0.5 million to the fund upon its request.

The carrying amount of $1.4 million reflects the net of the capital contribution, accumulative impairment charges and capital distributions.

Impairment

In the second quarter of fiscal 2010, we analyzed the fair value of the underlying investments of Skypoint Fund and concluded a portion of the carrying value was other-than-temporarily impaired and
recorded an impairment charge of $154,000 in addition to the $72,000 recorded in the first quarter of fiscal 2010.

NOTE 7. RELATED PARTY
TRANSACTION

Affiliates of Future Electronics Inc. (Future), Alonim Investments Inc. and two of its affiliates
(collectively Alonim), owned approximately 7.6 million shares, or approximately 17%, of our outstanding common stock as of December 27, 2009. As such, Alonim is our largest stockholder.

Our sales to Future are made at arms length under an agreement that provides protection against price reduction for its inventory of
our products and other sales allowances. We recognize revenue on sales to Future under the distribution agreement when Future sells the products to its end customers. Future has historically accounted for a significant portion of our net sales. It
is our largest distributor worldwide and accounted for 28% and 35% of our total net sales for the third quarters of fiscal 2010 and fiscal 2009, respectively. It accounted for 27% and 35% of our total net sales for the nine months ended
December 27, 2009 and December 28, 2008, respectively.



17



---

##### Table of Contents

We reimbursed Future for $7,000 and $21,000 of expenses for marketing promotional materials
for the third quarters of fiscal 2010 and fiscal 2009, respectively. We reimbursed Future for $27,000 and $38,000 of expenses for marketing promotional materials for the nine months ended December 27, 2009 and December 28, 2008,
respectively. A full discussion of our revenue accounting policies can be found in Part III, Item 8. Financial Statements and Supplementary Data, Note 2. Accounting Policiesof our Annual Report on Form 10-K for the fiscal
year ended March 29, 2009.

NOTE 8. RESTRUCTURING

As part of the Hifn acquisition we assumed a lease obligation for the Hifn facility located in Los Gatos, California, which expired in September 2009. As of September 27, 2009 there were no further
lease payments due. In addition, during the three and nine months ended December 27, 2009, we incurred severance expenses of $180,000 and $780,000 in connection with the Hifn acquisition, respectively.

As part of the Galazar acquisition we incurred severance cost of $100,000 and $234,000, respectively, for the three and nine months ended
December 27, 2009.

In connection with the Sipex acquisition in August 2007, our management approved and initiated
plans to restructure the operations of the combined company to eliminate certain duplicative activities, reduce costs and better align product and operating expenses with current economic conditions. The Sipex restructuring costs were accounted for
as liabilities assumed as part of the business combination.

Our restructuring liabilities were included in the Other
accrued expenses line item in our condensed consolidated balance sheets, and the activities affecting the liabilities for the three and nine months ended December 27, 2009 are summarized as follows (in thousands):



|                          |  |               |      |   |                |   |    |                             |  |   |      |  
|------------------------- |  | ------------- | ---- | - | -------------- | - | -- | --------------------------- |  | - | ---- | -
|                          |  | FacilityCosts |      |   | SeveranceCosts |   |    | TotalRestructuringLiability | 
|Balance at March 29, 2009 |  | $             | 375  |   |                | $ | 8  |                             |  | $ | 383  |  
|Payments                  |  |               | (272 | ) |                |   | (8 | )                           |  |   | (280 | )
|Additional accruals       |  |               | 202  |   |                |   |   |                             |  |   | 202  |  
|                          |  |               |      |   |                |   |    |                             |  |   |      |  
|Balance December 27, 2009 |  | $             | 305  |   |                | $ |   |                             |  | $ | 305  |  
|                          |  |               |      |   |                |   |    |                             |  |   |      |  

Of the $305,000 remaining facility related balance, $275,000 is expected to be paid
during the remaining term of the Sipex lease contract which extends through March 2012.

NOTE 9. INVENTORIES

As of December 27, 2009 and March 29, 2009, our inventories consisted of the following (in thousands):



|                  |  |                  |        |               |   |       
|----------------- |  | ---------------- | ------ | ------------- | - | ------
|                  |  | December 27,2009 |        | March 29,2009
|Work-in-process   |  | $                | 8,208  |               | $ | 9,175 
|Finished goods    |  |                  | 5,415  |               |   | 6,503 
|                  |  |                  |        |               |   |       
|Total Inventories |  | $                | 13,623 |               | $ | 15,678
|                  |  |                  |        |               |   |       



18



---

##### Table of Contents

NOTE 10. PROPERTY, PLANT AND EQUIPMENT

As of December 27, 2009 and March 29, 2009, our property, plant and equipment consisted of the following (in thousands):



|                                          |  |                  |         |   |               |   |         |  
|----------------------------------------- |  | ---------------- | ------- | - | ------------- | - | ------- | -
|                                          |  | December 27,2009 |         |   | March 29,2009 |  
|Land                                      |  | $                | 11,960  |   |               | $ | 11,960  |  
|Building and leasehold improvements       |  |                  | 23,383  |   |               |   | 22,641  |  
|Machinery and equipment                   |  |                  | 45,287  |   |               |   | 40,971  |  
|Software and licenses                     |  |                  | 34,001  |   |               |   | 28,704  |  
|                                          |  |                  |         |   |               |   |         |  
|Property, plant and equipment, total      |  |                  | 114,631 |   |               |   | 104,276 |  
|Accumulated depreciation and amortization |  |                  | (70,773 | ) |               |   | (61,727 | )
|                                          |  |                  |         |   |               |   |         |  
|Property, plant and equipment, net        |  | $                | 43,858  |   |               | $ | 42,549  |  
|                                          |  |                  |         |   |               |   |         |  

NOTE 11. LOSS PER SHARE

Basic loss per share, excludes dilution and is computed by dividing net income (loss) by the weighted average number of common shares
outstanding for the periods. Diluted earnings per share (EPS) reflects the potential dilution that would occur if outstanding stock options or warrants to issue common stock were exercised for common stock, and the common stock
underlying restricted stock units (RSUs) were issued using the treasury stock method.

A summary of our loss per
share for the periods presented is as follows (in thousands, except per share amounts):



|                                                                                                |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|----------------------------------------------------------------------------------------------- |  | ------------------ | ------ | - | ----------------- | - | ------- | ---------------- |  | - | ---------------- | - |  | - | ------- | -
|                                                                                                |  | Three Months Ended |        |   | Nine Months Ended |  
|                                                                                                |  | December 27,2009   |        |   | December 28,2008  |   |         | December 27,2009 |  |   | December 28,2008 |  
|Net loss                                                                                        |  | $                  | (3,762 | ) |                   | $ | (63,823 | )                |  | $ | (24,800          | ) |  | $ | (68,471 | )
|                                                                                                |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Shares used in computation:                                                                     |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Weighted average shares of common stock outstanding used in computation of basic loss per share |  |                    | 43,648 |   |                   |   | 42,889  |                  |  |   | 43,504           |   |  |   | 42,866  |  
|Dilutive effect of stock options and restricted stock units                                     |  |                    |       |   |                   |   |        |                  |  |   |                 |   |  |   |        |  
|                                                                                                |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Shares used in computation of diluted loss per share                                            |  |                    | 43,648 |   |                   |   | 42,889  |                  |  |   | 43,504           |   |  |   | 42,866  |  
|                                                                                                |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Loss per sharebasic and diluted                                                                |  | $                  | (0.09  | ) |                   | $ | (1.49   | )                |  | $ | (0.57            | ) |  | $ | (1.60   | )
|                                                                                                |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  

For the three and nine months ended December 27, 2009, as we incurred a net
loss, the weighted average number of shares of common stock outstanding equals the weighted average number of shares of common stock and common stock equivalent assuming dilution. Approximately 314,000 and 321,000 shares underlying options and RSUs
for the three and nine months ended December 27, 2009, respectively, were excluded from our loss per share calculation under the treasury method. Had we had income for the period, our diluted shares would have increased by the aforementioned
amounts.

For the three and nine months ended December 27, 2009, options to purchase approximately 5.1 million and
4.8 million shares of common stock, respectively, at exercise prices ranging from $7.11 to $86.10 and $6.97 to $86.10, respectively, were outstanding but were not included in the computation of diluted loss per share because they were
anti-dilutive under the treasury stock method. Warrants to purchase approximately 280,000 shares of common stock with an exercise price of $9.63 were also excluded from the computation of diluted loss per share because they were anti-dilutive under
the treasury stock method.

Our application of the treasury stock method in determining the dilutive effect of stock options
and RSUs includes assumed cash proceeds from option exercises, the average unamortized stock-based compensation expense for the period, and the estimated deferred tax benefit or detriment associated with stock-based compensation expense.



19



---

##### Table of Contents

NOTE 12. COMMON STOCK REPURCHASES

We acquire shares of our outstanding common stock in the open market from time to time to partially offset dilution from our stock awards
program, to increase our return on our invested capital and to bring our cash to a more appropriate level for our company. We may continue to utilize our stock purchase program described below, which would reduce our cash, cash equivalents and/or
short-term investments available to fund future operations and to meet other liquidity requirements.

On August 28, 2007,
we established a share repurchase plan (2007 SRP) and authorized the repurchase of up to $100 million of our common stock.

During the three and nine months ended December 27, 2009, we did not repurchase any shares under the 2007 SRP. We repurchased a total of 0.1 million and 1.6 million shares, respectively, of our common stock at an aggregate
cost of $0.5 million and $13.4 million, respectively, under the 2007 SRP during the three and nine months ended December 28, 2008.

As of December 27, 2009, the remaining authorized amount available under the 2007 SRP was $11.8 million. The 2007 SRP does not have a termination date.

NOTE 13. STOCK-BASED COMPENSATION

Employee Stock Participation Plan (ESPP)

Our ESPP permits employees to purchase common stock
through payroll deductions at a purchase price that is equal to 95% of our common stock price on the last trading day of each three-calendar-month offering period. Our ESPP is non-compensatory.

We are authorized to issue 4.5 million shares of common stock under our ESPP. There were 1.5 million shares of common stock
reserved for future issuance under our ESPP at December 27, 2009.

During the nine months ended December 27, 2009,
we issued 41,000 shares of our common stock at a weighted average price of $6.58 to the participating employees under our ESPP.

Equity
Incentive Plans

We currently have four equity incentive plans including the Exar Corporation 2006 Equity Incentive Plan
(the 2006 Plan) and three other equity plans assumed upon our August 2007 acquisition of Sipex: the Sipex Corporation 2000 Non-Qualified Stock Option Plan, the Sipex Corporation Amended and Restated 2002 Non-Statutory Stock Option Plan
and the Sipex Corporation 2006 Equity Incentive Plan (collectively, the Sipex Plans).

The 2006 Plan authorizes
the issuance of stock options, stock appreciation rights, restricted stock, stock bonuses and other forms of awards granted or denominated in common stock or units of common stock, as well as cash bonus awards. RSUs granted under the 2006 Plan are
counted against authorized shares available for future issuance on a basis of two shares for every RSU issued. The 2006 Plan allows for performance-based vesting and partial vesting based upon level of performance. Grants under the Sipex Plans are
only available to former Sipex employees or employees of the Company hired after the Sipex acquisition. At December 27, 2009, there were 1.8 million shares available for future grant under all our equity incentive plans.

As of December 27, 2009 and March 29, 2009, there were options to purchase 5.2 million and 3.4 million shares,
respectively, of our common stock outstanding under all stock option plans.



20



---

##### Table of Contents

Stock Option Activities

Our stock option transactions during the nine months ended December 27, 2009 are summarized as follows:



|                                               |  |             |   |  |                                       |       |                                         |      |                          |   |          
|---------------------------------------------- |  | ----------- | - |  | ------------------------------------- | ----- | --------------------------------------- | ---- | ------------------------ | - | ---------
|                                               |  | Outstanding |   |  | WeightedAverageExercisePrice perShare |       | WeightedAverageRemainingContractualTerm |      | AggregateIntrinsic Value
|                                               |  |             |   |  |                                       |       | (in years)                              |      |                         
|Balance at March 29, 2009                      |  | 3,406,091   |   |  | $                                     | 9.48  |                                         | 5.37 |                          | $ | 128,514  
|Options granted                                |  | 2,451,350   |   |  |                                       | 6.75  |                                         |      |                          |   |          
|Options exercised                              |  | (17,214     | ) |  |                                       | 5.77  |                                         |      |                          |   |          
|Options cancelled                              |  | (249,300    | ) |  |                                       | 14.55 |                                         |      |                          |   |          
|Options forfeited                              |  | (341,690    | ) |  |                                       | 8.96  |                                         |      |                          |   |          
|                                               |  |             |   |  |                                       |       |                                         |      |                          |   |          
|Balance at December 27, 2009                   |  | 5,249,237   |   |  | $                                     | 8.01  |                                         | 5.50 |                          | $ | 1,524,195
|                                               |  |             |   |  |                                       |       |                                         |      |                          |   |          
|Vested and expected to vest, December 27, 2009 |  | 4,613,341   |   |  | $                                     | 8.09  |                                         | 5.45 |                          | $ | 1,331,976
|                                               |  |             |   |  |                                       |       |                                         |      |                          |   |          

The aggregate intrinsic values in the table above represent the total pre-tax
intrinsic value, which is based on the closing price of our common stock of $7.14 and $6.17 as of December 27, 2009 and March 29, 2009, respectively. These are the values which would have been received by option holders if all option
holders exercised their options on that date.

The total number of vested and exercisable in-the-money options was
0.2 million shares as of each of December 27, 2009 and March 29, 2009.

Total unrecognized stock-based
compensation cost was $9.2 million at December 27, 2009, which is expected to be recognized over a weighted average period of 3.0 years.

RSUs

Our RSU transactions during the nine months ended
December 27, 2009 are summarized as follows:



|                              |  |          |   |  |                                            |      |                                                   |      |                          |   |          
|----------------------------- |  | -------- | - |  | ------------------------------------------ | ---- | ------------------------------------------------- | ---- | ------------------------ | - | ---------
|                              |  | Shares   |   |  | WeightedAverageGrand-Date FairMarket Value |      | WeightedAverageRemainingContractualTerm(in Years) |      | AggregateIntrinsic Value
|Unvested at March 29, 2009    |  | 730,237  |   |  | $                                          | 8.36 |                                                   | 1.14 |                          | $ | 4,505,562
|Granted                       |  | 541,384  |   |  |                                            | 7.24 |                                                   |      |                          |   |          
|Issued and released           |  | (324,425 | ) |  |                                            | 6.89 |                                                   |      |                          |   |          
|Cancelled                     |  | (69,904  | ) |  |                                            | 9.24 |                                                   |      |                          |   |          
|                              |  |          |   |  |                                            |      |                                                   |      |                          |   |          
|Unvested at December 27, 2009 |  | 877,292  |   |  | $                                          | 8.08 |                                                   | 1.25 |                          | $ | 6,263,865
|                              |  |          |   |  |                                            |      |                                                   |      |                          |   |          

In July 2009, we granted performance-based RSUs covering 99,000 shares to certain
executives, issuable upon meeting certain performance targets in our fiscal 2010 and vesting annually over a three year period beginning July 1, 2010. The annual vesting requires continued service through each annual vesting date. Based on our
assessment of meeting the performance targets established and the probability that these targets will be achieved, we recorded no compensation expense related to these grants for the three and nine months ended December 27, 2009. No such grants
were made in the three and nine months ended December 28, 2008.

The aggregate intrinsic value of RSUs represents the
closing price per share of our stock at the end of the periods presented, multiplied by the number of unvested RSUs at the end of each period.

For RSUs, stock-based compensation expense was calculated based on our stock price on the date of grant, multiplied by the number of RSUs granted. The grant date fair value of RSUs, less estimated
forfeitures, is recognized on a straight-line basis over the vesting period.



21



---

##### Table of Contents

At December 27, 2009, there were RSUs corresponding to approximately 0.9 million
shares of our common stock outstanding with an unrecognized stock-based compensation cost of approximately $4.0 million to be recognized as compensation expense over a weighted average period of 1.22 years.

Stock-Based Compensation Expense

The following table summarized stock-based compensation expense, in accordance with FASB authoritative guidance, related to stock options and RSUs during the fiscal periods presented (in thousands):



|                                       |  |                    |       |                   |   |                  |  |                  |       |  |   |      
|-------------------------------------- |  | ------------------ | ----- | ----------------- | - | ---------------- |  | ---------------- | ----- |  | - | -----
|                                       |  | Three Months Ended |       | Nine Months Ended
|                                       |  | December 27,2009   |       | December 28,2008  |   | December 27,2009 |  | December 28,2008
|Cost of sales                          |  | $                  | 117   |                   | $ | 105              |  | $                | 384   |  | $ | 471  
|Research and development               |  |                    | 467   |                   |   | 392              |  |                  | 1,701 |  |   | 1,231
|Selling, general and administrative    |  |                    | 752   |                   |   | 769              |  |                  | 2,226 |  |   | 2,013
|                                       |  |                    |       |                   |   |                  |  |                  |       |  |   |      
|Total stock-based compensation expense |  | $                  | 1,336 |                   | $ | 1,266            |  | $                | 4,311 |  | $ | 3,715
|                                       |  |                    |       |                   |   |                  |  |                  |       |  |   |      

Stock-based compensation expense for the three and nine months ended
December 27, 2009 includes $138,000 and $426,000, respectively, of incremental stock-based compensation expense, associated with RSU awards covering an aggregate of 344,000 shares of our common stock issued in exchange for the options
surrendered pursuant to the October 23, 2008 option exchange program. Refer to our Form 10-K for the fiscal year ended March 29, 2009 for a full disclosure on our option exchange program.

Valuation Assumptions

We estimate the fair value of stock options on the date of grant using the Black-Scholes option-pricing model. The assumptions used in calculating the fair value of stock-based compensation represent our
estimates, but these estimates involve inherent uncertainties and the application of management judgments which include the expected term of the share-based awards, stock price volatility and forfeiture rates. As a result, if factors change and we
use different assumptions, our stock-based compensation expense could be materially different in the future.

We used the
following weighted average assumptions to calculate the fair values of options granted during the fiscal periods presented:



|                                      |  |                    |           |   |                   |   |           |                  |  |   |                  |   |  |   |           |  
|------------------------------------- |  | ------------------ | --------- | - | ----------------- | - | --------- | ---------------- |  | - | ---------------- | - |  | - | --------- | -
|                                      |  | Three Months Ended |           |   | Nine Months Ended |  
|                                      |  | December 27,2009   |           |   | December 28,2008  |   |           | December 27,2009 |  |   | December 28,2008 |  
|Expected term of options (years)      |  |                    | 4.7  4.9 |   |                   |   | 4.6  4.8 |                  |  |   | 4.7  4.9        |   |  |   | 4.6  4.8 |  
|Risk-free interest rate               |  |                    | 2.2  2.3 | % |                   |   | 1.9  2.0 | %                |  |   | 2.1  2.5        | % |  |   | 1.9  3.2 | %
|Expected volatility                   |  |                    | 37  38   | % |                   |   | 35        | %                |  |   | 37  38          | % |  |   | 30  35   | %
|Expected dividend yield               |  |                    |          |   |                   |   |          |                  |  |   |                 |   |  |   |          |  
|Weighted average estimated fair value |  | $                  | 2.47      |   |                   | $ | 2.17      |                  |  | $ | 2.40             |   |  | $ | 2.58      |  

NOTE 14. COMPREHENSIVE INCOME (LOSS)

Our comprehensive loss for the fiscal periods presented was as follows (in thousands):



|                                                                         |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|------------------------------------------------------------------------ |  | ------------------ | ------ | - | ----------------- | - | ------- | ---------------- |  | - | ---------------- | - |  | - | ------- | -
|                                                                         |  | Three Months Ended |        |   | Nine Months Ended |  
|                                                                         |  | December 27,2009   |        |   | December 28,2008  |   |         | December 27,2009 |  |   | December 28,2008 |  
|Net loss                                                                 |  | $                  | (3,762 | ) |                   | $ | (63,823 | )                |  | $ | (24,800          | ) |  | $ | (68,471 | )
|Other comprehensive loss:                                                |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Change in unrealized income (loss), on marketable securities, net of tax |  |                    | (223   | ) |                   |   | 1,836   |                  |  |   | 689              |   |  |   | (171    | )
|                                                                         |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Total other comprehensive income (loss)                                  |  |                    | (223   | ) |                   |   | 1,836   |                  |  |   | 689              |   |  |   | (171    | )
|                                                                         |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  
|Comprehensive loss                                                       |  | $                  | (3,985 | ) |                   | $ | (61,987 | )                |  | $ | (24,111          | ) |  | $ | (68,642 | )
|                                                                         |  |                    |        |   |                   |   |         |                  |  |   |                  |   |  |   |         |  



22



---

##### Table of Contents

NOTE 15. LEASE FINANCING OBLIGATION

In connection with our August 2007 acquisition of Sipex, we assumed a lease financing obligation related to a facility located in Milpitas,
California (the Hillview Facility). The lease term expires in March 2011 with average lease payments over the term of approximately $1.4 million per year.

The fair value of the Hillview Facility was estimated at $13.4 million at the time of the acquisition and was included in the Property, plant and equipment, net line item on the condensed
consolidated balance sheets. In accordance with purchase accounting, we have accounted for this sale and leaseback transaction as a financing transaction with the obligation included in the Short-term and Long-term lease financing
obligations line items on our condensed consolidated balance sheets. The effective interest rate is 8.2%. Depreciation for the Hillview Facility was recorded over the straight-line method for the remaining useful life and was $88,000 and
$264,000, respectively, for the three and nine months ended December 27, 2009.

At the end of the lease term, the
estimated final lease obligation will be approximately $12.2 million, which we will settle by returning the Hillview Facility to the lessor.

We sublet the Hillview Facility in April 2008. The sublease expires in March 2011 and we expect annual sublease income of approximately $1.4 million for the duration of the sublease term. The sublease
income for the three and nine months ended December 27, 2009 was $353,000 and $1.1 million, respectively, and was recorded in the Interest income and other, net line item in our condensed consolidated statements of operations.

We have also acquired engineering design tools (design tools) under capital leases and have recorded them in the
Property, plant and equipment, net line item on the condensed consolidated balance sheets. The related design tool obligations were included in the Short-term and Long-term lease financing obligations lines item in our
condensed consolidated balance sheets.

Future minimum lease payments for the lease financing obligations as of
December 27, 2009 were as follows (in thousands):



|                                                    |  |                  |        |   |             |   |        |       |  |   |                        |   |  |   |      
|--------------------------------------------------- |  | ---------------- | ------ | - | ----------- | - | ------ | ----- |  | - | ---------------------- | - |  | - | -----
|Fiscal Years                                        |  | HillviewFacility |        |   | DesignTools |   |        | Total |  |   | ExpectedSubleaseIncome
|2010 (3 months remaining)                           |  | $                | 353    |   |             | $ | 1,013  |       |  | $ | 1,366                  |   |  | $ | 353  
|2011                                                |  |                  | 13,624 |   |             |   | 3,676  |       |  |   | 17,300                 |   |  |   | 1,412
|2012                                                |  |                  |       |   |             |   | 1,442  |       |  |   | 1,442                  |   |  |   |     
|                                                    |  |                  |        |   |             |   |        |       |  |   |                        |   |  |   |      
|Total minimum lease payments                        |  |                  | 13,977 |   |             |   | 6,131  |       |  |   | 20,108                 |   |  |   | 1,765
|Less: amount representing interest                  |  |                  | (1,280 | ) |             |   | (471   | )     |  |   | (1,751                 | ) |  |   |     
|Less: amount representing maintenance               |  |                  |       |   |             |   | (309   | )     |  |   | (309                   | ) |  |   |     
|                                                    |  |                  |        |   |             |   |        |       |  |   |                        |   |  |   |      
|Present value of minimum lease payments             |  |                  | 12,697 |   |             |   | 5,351  |       |  |   | 18,048                 |   |  |   | 1,765
|Less: current portion of lease financing obligation |  |                  | (417   | ) |             |   | (3,104 | )     |  |   | (3,521                 | ) |  |   |     
|                                                    |  |                  |        |   |             |   |        |       |  |   |                        |   |  |   |      
|Long-term lease financing obligation                |  | $                | 12,280 |   |             | $ | 2,247  |       |  | $ | 14,527                 |   |  | $ | 1,765
|                                                    |  |                  |        |   |             |   |        |       |  |   |                        |   |  |   |      

For the three and nine months ended December 27,
2009, interest expense totaled $320,000 and $966,000, respectively, for the Hillview Facility lease financing obligation and design tools. For the three and nine months ended December 28, 2008, interest expense totaled $323,000 and $954,000,
respectively, for the Hillview Facility lease financing obligation and design tools.

Of the $13.6 million to be paid in
fiscal year 2011, $1.4 million will be paid in cash and the remainder will be settled by returning the Hillview Facility to the lessor at the end of the lease term in March 2011.

NOTE 16. COMMITMENTS AND CONTINGENCIES

In 1986, Micro Power Systems Inc.
(MPSI), a subsidiary that we acquired in June 1994, identified low-level groundwater contamination at its principal manufacturing site. The area and extent of the contamination appear to have been defined. MPSI previously reached an
agreement with a prior tenant to share in the cost of ongoing site investigations and the operation of remedial systems to remove subsurface chemicals. The frequency and number of wells monitored at the site was reduced with prior regulatory
approval for a plume stability analysis as an initial step towards site closure. No significant rebound concentrations have been observed. The groundwater treatment system remains shut down. In July 2008, we evaluated the effectiveness of the plume
stability and decided to initiate an alternative treatment program to pursue a no further action order for the site. The program was approved by the state and implementation started in October 2009. As such, we accrued an additional $58,000,
increasing our liability to $250,000. This accrual includes approximately $200,000 for various remediation options under consideration and $50,000 for future annual monitoring. As of December 27, 2009 the outstanding liability was $147,000, net
of payments of $103,000, during the nine months ended December 27, 2009.



23



---

##### Table of Contents

Sipex, which we acquired in August 2007, entered into a definitive Master Agreement with
Hangzhou Silan Microelectronics Co. Ltd. and Hangzhou Silan Integrated Circuit Co. Ltd. (collectively Silan) in China. Silan is a China-based semiconductor foundry. This transaction was related to the closing of Sipex wafer fabrication
operations located in Milpitas, California. Under this agreement, Sipex and Silan would work together to enable Silan to manufacture semiconductor wafers using Sipex process technology. The Master Agreement includes a Process Technology Transfer and
License Agreement which contemplates the transfer of eight of our processes and related product manufacturing to Silan. Subject to our option to suspend in whole or in part, there is a purchase commitment under the Wafer Supply Agreement obligating
us to purchase from Silan an average of at least one thousand equivalent wafers per week, calculated on a quarterly basis, for five years beginning February 2006. There were open purchase orders for approximately $1.8 million outstanding as of
December 27, 2009.

Generally, we warrant all of our products against defects in materials and workmanship for a period
of 90 days and occasionally we may provide an extended warranty of up to two years from the delivery date. Reserve requirements are recorded in the period of sale and are based on an assessment of the products sold with warranty and historical
warranty costs incurred. Our liability is generally limited to replacing, repairing or issuing credit, at our option, for the product if it has been paid for. The warranty does not cover damage which results from accident, misuse, abuse, improper
line voltage, fire, flood, lightning or other damage resulting from modifications, repairs or alterations performed other than by us, or resulting from failure to comply with our written operating and maintenance instructions. Warranty expense has
historically been immaterial for our products. The warranty liabilities related to our products as of December 27, 2009 were immaterial.

Additionally, our sales agreements indemnify our customers for expenses or liability resulting from alleged or claimed infringement by our products of any U.S. letter patents of third parties. However, we
are not liable for any collateral, incidental or consequential damages arising out of patent infringement. The terms of these indemnification agreements are perpetual, commencing after execution of the sales agreement or the date indicated on our
order acknowledgement. The maximum amount of potential future indemnification is unlimited. However, to date, we have not paid any claims or been required to defend any lawsuits with respect to any such indemnity claim.

NOTE 17. LEGAL PROCEEDINGS

From time to time, we are involved in various claims, legal actions and complaints arising in the normal course of business. Although the ultimate outcome of the matters discussed below and other matters is not presently determinable,
management currently believes that the resolution of all such pending matters will not have a material adverse effect on our financial position, results of operations or liquidity.

Ericsson Wireless Communications, Inc. and Vicor Corporation

On
November 16, 2004, Ericsson Wireless Communications, Inc. (now known as Ericsson Inc.) (Ericsson) initiated a lawsuit against us and our former customer, Vicor Corporation, in San Diego County Superior Court. Ericsson alleged that
Vicor had sold it products that contained defects, including defects in the integrated circuits derived from the untested, semi-custom wafers we sold to Vicor. Ericsson sought monetary damages and unspecified injunctive relief. On April 5,
2005, Vicor Corporation (Vicor) filed a cross-complaint against us in San Diego County Superior Court asserting various contract, tort, and indemnity claims. Only the indemnity claims survived the pleading stage. In those claims, Vicor
alleged, among other things, that we were responsible for the alleged defect in the products sold to Ericsson and that any damages awarded to Ericsson should be born solely by us. Ultimately, we settled the case with Ericsson and the claims against
us were dismissed with prejudice. In addition, we obtained a finding from the trial court that the settlement with Ericsson was in good faith. The result of the good faith finding was that final judgment was entered in our favor on Vicors
indemnity claims, a judgment which has been finally affirmed on appeal.

On March 4, 2005, we filed a complaint in Santa
Clara County Superior Court against Vicor. In the complaint, we sought a declaration regarding the respective rights and obligations, including warranty and indemnity rights and obligations, under the written contracts between us and Vicor for the
sale of untested, semi-custom wafers. In addition, we sought a declaration that we were not responsible for any damages that Vicor must pay to Ericsson or any other customer of Vicor arising from claims that Vicor sold allegedly defective products.
On March 17, 2005, Vicor filed a cross-complaint against us (and the owners and operators of the foundry which supplied the untested, semi-custom wafers that we sold to Vicor). In the cross-complaint, Vicor asserted that it is entitled to
indemnification from us for any damages that Vicor must pay to Ericsson or other Vicor customers resulting from Vicors sale of allegedly defective products. Following a motion to dismiss, Vicor filed an amended cross-complaint on
August 1, 2005 asserting only a request for a declaration that we were obligated to indemnify Vicor for any damages resulting from claims brought against Vicor by its customers. We answered Vicors amended cross-complaint on
September 2, 2005. The Santa Clara action was transferred to San Diego for coordination with the Ericsson San Diego County action on August 18, 2006. On September 29, 2009,



24



---

##### Table of Contents

Exar and Vicor entered into a settlement agreement that resolves all outstanding claims between the parties in exchange for an undisclosed payment from Vicor to Exar. A joint request for
dismissal of the one pending action between the parties has been filed, and entered by the Court in San Diego County. All pending actions between Exar and Vicor have now been dismissed.

DiPietro v. Sipex

In April 2003, plaintiff Frank DiPietro (former chief
financial officer of Sipex) brought an action for breach of contract against Sipex in the Middlesex Superior Court in the state of Massachusetts. Mr. DiPietro was seeking approximately $800,000 in severance benefits. Sipex counterclaimed for
approximately $150,000, which it was owed under a promissory note signed by Mr. DiPietro. In August 2004, Sipex filed two motions for summary judgment (one for Mr. DiPietros claims against it and one for its counterclaim against
Mr. DiPietro). In June 2005, the Middlesex Superior Court granted both Sipexs motions for summary judgment. Soon thereafter, Mr. DiPietro filed a notice of appeal. Sipex then filed motions for costs and pre-judgment interest. Sipex
was successful in its motion for prejudgment interest and it was successful in requiring Mr. DiPietro to pay over $900 in deposition costs.

The appeal briefing was completed during the summer of 2006. On December 12, 2006, the Massachusetts Appeals Court heard arguments in DiPietro v. Sipex and, on May 14, 2007, the
Appeals Court issued its decision reversing the Middlesex Superior Courts grant of summary judgment and remanding the case for further proceedings. Sipex filed a petition for rehearing and an application for further appellate
review. After briefing by the parties, the Massachusetts Appeals Court amended its decision to clarify issues addressed in Sipexs petition for rehearing. On October 31, 2007, Sipexs application for further appellate review was
denied.

The case was remanded to Middlesex Superior Court for further proceedings. Sipex served its motion for leave to
file renewed motions for summary judgment on August 11, 2008, and Mr. DiPietro served his opposition on August 21, 2008. On October 14, 2008, the Court heard arguments on Sipexs motion for leave to file renewed motions for
summary judgment. The Court denied Sipexs motion on October 16, 2008. A pre-trial conference was held on February 3, 2009. At that time, opposing counsel requested a continuance due to a family emergency, and the trial was
rescheduled for April 27, 2009. After a further continuance, the trial was scheduled for July 27, 2009. Before the scheduled trial date of July 27, 2009 commenced, the parties were able to negotiate a settlement
agreement. A final settlement agreement was executed and the joint stipulation of dismissal was filed and entered by the Superior Court on August 14, 2009. All pending actions between Exar and Mr. DiPietro
have now been dismissed.

NOTE 18. INCOME TAX

During the three months ended December 27, 2009 and December 28, 2008, we recorded an income tax benefit of $43,000 and $70,000, respectively. During the nine months ended December 27, 2009
and December 28, 2008, we recorded an income tax benefit of $652,000 and $129,000, respectively. During the three and nine months ended December 27, 2009, the tax benefit recorded was primarily due to benefits recorded for true-up
adjustment for prior year tax expense and net operating losses.

Unrecognized tax benefits increased by $2.6 million, from
$13.2 million to $15.8 million, during the three months ended December 27, 2009. The increase in unrecognized tax benefits was primarily a result of increased unrecognized tax benefits on R&D tax credits and the allocation of income and
expense among operating entities that was partially offset by a decrease in the unrecognized tax benefits due to the release of FIN 48 reserves related to the expiration of the statute of limitations. If recognized, $13.3 million of these
unrecognized tax benefits (net of federal benefit) would be recorded as a reduction of future income tax provision before consideration of changes in the valuation allowance.

Estimated interest and penalties related to income taxes are classified as a component of the provision for income taxes in our condensed
consolidated statement of operations. Accrued interest and penalties were $0.3 million at the end of the third quarters of each of fiscal 2010 and 2009, respectively.

Our only major tax jurisdictions are the United States federal and those of various states. The fiscal years 1998 through 2009 remain open
and subject to examinations by the appropriate governmental agencies in the United States, with fiscal years 2001 through 2009 open to audits in certain of our state jurisdictions.



25



---

##### Table of Contents

NOTE 19. SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one reportable segment. We design, develop and market high-performance, analog and mixed-signal silicon solutions for a variety
of markets including power management, interface and datacom. The nature of our products and production processes and the type of customers and distribution methods are consistent among all of our products.

Our net sales by product line for the fiscal periods presented are summarized as follows (in thousands):



|                 |  |                    |        |                   |   |                  |  |                  |        |  |   |       
|---------------- |  | ------------------ | ------ | ----------------- | - | ---------------- |  | ---------------- | ------ |  | - | ------
|                 |  | Three Months Ended |        | Nine Months Ended
|                 |  | December 27,2009   |        | December 28,2008  |   | December 27,2009 |  | December 28,2008
|Datacom          |  | $                  | 12,416 |                   | $ | 6,191            |  | $                | 36,580 |  | $ | 21,513
|Interface        |  |                    | 15,655 |                   |   | 14,062           |  |                  | 43,529 |  |   | 50,542
|Power Management |  |                    | 5,860  |                   |   | 6,052            |  |                  | 16,272 |  |   | 19,209
|                 |  |                    |        |                   |   |                  |  |                  |        |  |   |       
|Total net sales  |  | $                  | 33,931 |                   | $ | 26,305           |  | $                | 96,381 |  | $ | 91,264
|                 |  |                    |        |                   |   |                  |  |                  |        |  |   |       

Our foreign operations are conducted primarily through
our wholly-owned subsidiaries in Canada, China, France, Germany, Italy, Japan, Malaysia, Singapore, South Korea, Taiwan and the United Kingdom. Our principal markets include North America, Europe and the Asia Pacific region. Net sales by geographic
area represent sales to unaffiliated customers.

Our net sales by geographic area for the fiscal periods presented are
summarized as follows (in thousands):



|                        |  |                    |        |                   |   |                  |  |                  |        |  |   |       
|----------------------- |  | ------------------ | ------ | ----------------- | - | ---------------- |  | ---------------- | ------ |  | - | ------
|                        |  | Three Months Ended |        | Nine Months Ended
|                        |  | December 27,2009   |        | December 28,2008  |   | December 27,2009 |  | December 28,2008
|United States           |  | $                  | 9,079  |                   | $ | 6,664            |  | $                | 24,757 |  | $ | 23,091
|China                   |  |                    | 10,904 |                   |   | 5,950            |  |                  | 33,800 |  |   | 20,197
|Singapore               |  |                    | 3,907  |                   |   | 3,240            |  |                  | 10,530 |  |   | 11,682
|Japan                   |  |                    | 2,080  |                   |   | 1,578            |  |                  | 5,446  |  |   | 6,273 
|Italy                   |  |                    | 727    |                   |   | 1,687            |  |                  | 2,246  |  |   | 4,394 
|Europe (excludes Italy) |  |                    | 4,175  |                   |   | 4,529            |  |                  | 11,422 |  |   | 15,447
|Rest of world           |  |                    | 3,059  |                   |   | 2,657            |  |                  | 8,180  |  |   | 10,180
|                        |  |                    |        |                   |   |                  |  |                  |        |  |   |       
|Total net sales         |  | $                  | 33,931 |                   | $ | 26,305           |  | $                | 96,381 |  | $ | 91,264
|                        |  |                    |        |                   |   |                  |  |                  |        |  |   |       

Substantially all of our long-lived assets at each of
December 27, 2009 and March 29, 2009 were located in the United States.

NOTE 20. SUBSEQUENT EVENTS

Management evaluated all subsequent events through February 5, 2010, the date the financial statements were issued.



|ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|------- | -------------------------------------------------------------------------------------

The following Managements Discussion and Analysis of Financial Condition and Results of Operations, as well as information
contained in Part II, Item 1A. Risk Factors below and elsewhere in this Quarterly Report on Form 10-Q, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are generally written in the future tense and/or may generally be identified by words such as will, may, should,
could, expect, suggest, believe, anticipate, intend, plan, or other similar words. Forward-looking statements contained in this Quarterly Report include, among
others, statements regarding (1) our revenue growth, (2) our future gross profits, (3) our future research and development efforts and related expenses, (4) our future selling, general and administrative expenses, (5) our
cash and cash equivalents, short-term marketable securities and cash flows from operations being sufficient to satisfy working capital requirements and capital equipment needs for at least the next 12 months, (6) our ability to continue to
finance operations with cash flows from operations, existing cash and investment balances, and some combination of long-term debt and/or lease financing and sales of equity securities, (7) the possibility of future acquisitions and investments,
(8) our ability to accurately estimate our assumptions used in valuing stock-based compensation, (9) our ability to estimate and reconcile distributors reported inventories to their activities, (10) our ability to estimate
future cash flows associated with long-lived assets, (11) the volatile global economic and financial market conditions, and (12) anticipated results in connection



26



---

##### Table of Contents

with the acquisition of hi/fn, inc. (Hifn) and Galazar Networks Inc. (Galazar). Actual results may differ materially from those projected in the forward-looking
statements as a result of various factors. Factors that could cause actual results to differ materially from those stated herein include, but are not limited to: the information contained under the captions Part I, Item 2.
Managements Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors. We disclaim any obligation to update information in any forward-looking statement.

The following Managements Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction
with the condensed consolidated financial statements and notes thereto, included in this Quarterly Report on Form 10-Q, and our audited consolidated financial statements for the fiscal year ended March 29, 2009 included in our Annual Report on
Form 10-K, as filed with the Securities and Exchange Commission (SEC). Our results of operations for the three and nine months ended December 27, 2009 are not necessarily indicative of results to be expected for any future period.

BUSINESS OVERVIEW

Exar Corporation and its subsidiaries (Exar or we) is a fabless semiconductor company that designs, sub-contracts manufacturing of and sells highly differentiated silicon, software
and subsystem solutions for industrial, datacom and storage applications. We use our extensive knowledge of end-user markets along with our underlying analog, mixed signal and digital technology to provide customers with innovative solutions
designed to meet the needs of the evolving connected world. Our product portfolio includes power management and interface components, datacom products, storage optimization solutions, network security and applied service processors. Applying both
analog and digital technologies, our products are deployed in a wide array of applications such as portable electronic devices, set top boxes, digital video recorders, telecommunication systems, servers, enterprise storage systems and industrial
automation equipment. We provide customers with a breadth of component products and subsystem solutions based on advanced mixed signal silicon integration.

We market our products worldwide with sales offices and personnel located throughout the Americas, Europe, and Asia. Our products are sold in the United States through a number of manufacturers
representatives and distributors. Internationally, our products are sold through various regional and country specific distributors with locations in thirty-three countries around the globe. In addition to our sales offices, we also employ a
worldwide team of field application engineers to work directly with our customers.

Our international sales consist of sales
that are denominated in U.S. dollars. Our international related operations expenses expose us to fluctuations in currency exchange rates because our foreign operating expenses are denominated in foreign currency while our sales are denominated in
U.S. dollars. Although foreign sales within certain countries or foreign sales comprised of certain products may subject us to tariffs, our gross profit margin on international sales, adjusted for differences in product mix, is not significantly
different from that realized on our sales to domestic customers. Our operating results are subject to quarterly and annual fluctuations as a result of several factors that could materially and adversely affect our future profitability as described
in Part II, Item 1A. Risk FactorsOur Financial Results May Fluctuate Significantly Because Of A Number Of Factors, Many Of Which Are Beyond Our Control.

Our fiscal years consist of 52 or 53 weeks. In a 52-week year, each fiscal quarter consist of 13 weeks. The additional week in a
53-week year is added to the fourth quarter, making such quarter consist of 14 weeks. Fiscal year 2010 and fiscal year 2009 are comprised of a 52-week period.

Business Combinations

On June 17, 2009, we completed the acquisition
of Galazar for approximately $4.95 million in cash. Galazar, based in Ottawa, Canada, is a fabless semiconductor and software supplier focused on carrier grade transport over telecom networks. Galazars product portfolio addresses transport of
a wide range of datacom and telecom services including Ethernet, SAN, TDM and video over SONET/SDH, PDH and OTN networks.

On
April 3, 2009, we completed the acquisition of Hifn, a fabless semiconductor company that was founded in 1996, spun off from Stac, Inc. in 1999 and traded on the NASDAQ under the symbol HIFN since 1999, for total consideration of
approximately $59.6 million, which consisted of 429,600 shares of Exars common stock with an estimated fair value of approximately $2.8 million, and $56.8 million in cash. The acquisition of Hifn expands and complements our product offerings
in the enterprise storage, networking and telecom markets where we have had a significant base of business for more than 10 years. The Hifn technology adds world class compression and data deduplication products used in storage applications to
optimize data and speed up data backup and retrieval. Hifn has also been a leading provider in security acceleration technology by providing encryption and compression products to the leading networking and telecom system manufacturers. The Hifn
products complement the existing Exar connectivity solutions and provide us with a more significant product offering to our customers.



27



---

##### Table of Contents

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The preparation of our financial statements and accompanying disclosures in conformity with GAAP requires estimates and assumptions that
affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes. The SEC has defined a
companys critical accounting policies as policies that are most important to the portrayal of a companys financial condition and results of operations, and which require a company to make its most difficult and subjective judgments,
often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, we have identified our most critical accounting policies and estimates to be as follows: (1) revenue recognition;
(2) valuation of inventories; (3) income taxes; (4) stock-based compensation; (5) goodwill; (6) long-lived assets; and (7) valuation of business combinations. Although we believe that of our estimates, assumptions and
judgments are reasonable, they are based upon information presently available. Actual results may differ significantly from these estimates if the assumptions, judgments and conditions upon which they are based turn out to be inaccurate. A further
discussion of our critical accounting policies can be found in Part II, Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the fiscal year
ended March 29, 2009.

RESULTS OF OPERATIONS

We acquired Hifn on April 3, 2009 and Galazar on June 17, 2009 and consequently, our results of operations for the three and nine months ended December 27, 2009 include the results of those
entities from the reported acquisition dates.

The increase in our net sales for the nine months ended December 27, 2009
as compared to the same period a year ago reflects the inclusion of sales derived from our Hifn and Galazar acquisitions partially offset by the effect of the downturn in the worldwide economy and its severe impact on the semiconductor
industry. The increase in our net sales for the three months ended December 27, 2009 as compared to the same period a year ago reflects the inclusion of Hifn and Galazar net sales in the current fiscal period and the partial recovery of
the semiconductor industry.

Net Sales by Product Line

Our net sales by product line in dollars and as a percentage of net sales were as follows for the fiscal periods presented (in thousands):



|                 |  |                    |        |  |                  |   |  |                   |                  |  |     |                  |  |     |        |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|---------------- |  | ------------------ | ------ |  | ---------------- | - |  | ----------------- | ---------------- |  | --- | ---------------- |  | --- | ------ |  | - | ------ |  | --- | - |  | - | ------ |  | --- | - |  | --- | --
|                 |  | Three Months Ended |        |  | Change           |   |  | Nine Months Ended |                  |  |     |                 
|                 |  | December 27,2009   |        |  | December 28,2008 |   |  |                   | December 27,2009 |  |     | December 28,2008 |  |     | Change | 
|Net Sales:       |  |                    |        |  |                  |   |  |                   |                  |  |     |                  |  |     |        |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|Datacom          |  | $                  | 12,416 |  | 37               | % |  | $                 | 6,191            |  | 24  | %                |  | 101 | %      |  | $ | 36,580 |  | 38  | % |  | $ | 21,513 |  | 24  | % |  | 70  | % 
|Interface        |  |                    | 15,655 |  | 46               | % |  |                   | 14,062           |  | 53  | %                |  | 11  | %      |  |   | 43,529 |  | 45  | % |  |   | 50,542 |  | 55  | % |  | (14 | %)
|Power Management |  |                    | 5,860  |  | 17               | % |  |                   | 6,052            |  | 23  | %                |  | (3  | %)     |  |   | 16,272 |  | 17  | % |  |   | 19,209 |  | 21  | % |  | (15 | %)
|                 |  |                    |        |  |                  |   |  |                   |                  |  |     |                  |  |     |        |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|Total            |  | $                  | 33,931 |  | 100              | % |  | $                 | 26,305           |  | 100 | %                |  |     |        |  | $ | 96,381 |  | 100 | % |  | $ | 91,264 |  | 100 | % |  |     |   
|                 |  |                    |        |  |                  |   |  |                   |                  |  |     |                  |  |     |        |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   

Datacom

Datacom products include network access, transmission and storage products, as well as encryption, data reduction and packet processing
products from the Hifn acquisition and network transport products from the Galazar acquisition.

For the three months ended
December 27, 2009, net sales of datacom products increased $6.2 million as compared to the same period a year ago and included $7.3 million of additional sales from Hifn and Galazar products. Net of this effect, net sales of network access,
transmission and storage products for the third quarter of fiscal 2010 decreased $1.1 million primarily due to decreased volume of our SONET products.

For the nine months ended December 27, 2009, net sales of datacom products increased $15.1 million as compared to the same period a year ago and included $20.4 million of additional sales from Hifn
and Galazar products. Net of this effect, net sales of network access, transmission and storage products for the nine months ended December 27, 2009 decreased $5.3 million, primarily due to decreased volume of our SONET and optical products.



28



---

##### Table of Contents

Interface

Interface products include Universal Asynchronous Receiver/Transmitter (UARTs) and serial transceiver products.

For the three months ended December 27, 2009, net sales of interface products increased $1.6 million as compared to the same period a
year ago, primarily due to increased volume of UARTs and serial transceiver sales.

For the nine months ended
December 27, 2009, net sales of interface products decreased $7.0 million as compared to the same period a year ago, primarily due to decreased volume of UARTs and serial transceiver sales

Power Management

Power management products include DC-DC regulators and LED drivers.

For the three months ended December 27,
2009, net sales of power management products decreased $0.2 million as compared to the same period a year ago, primarily due to price erosion on a limited number of products.

For the nine months ended December 27, 2009, net sales of power management products decreased $2.9 million as compared to the same
period a year ago, primarily due to decreased volumes and price erosion on a limited number of products.

Net Sales by Channel

Our net sales by channel in dollars and as a percentage of net sales were as follows for the fiscal periods presented (in
thousands):



|                          |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |    |   |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|------------------------- |  | ------------------ | ------ |  | ---------------- | - |  | ----------------- | ---------------- |  | ------ | ---------------- |  | -- | - |  | - | ------ |  | --- | - |  | - | ------ |  | --- | - |  | --- | --
|                          |  | Three Months Ended |        |  | Change           |   |  | Nine Months Ended |                  |  | Change |                 
|                          |  | December 27,2009   |        |  | December 28,2008 |   |  |                   | December 27,2009 |  |        | December 28,2008 |  |   
|Net Sales:                |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |    |   |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|Sell-through distributors |  | $                  | 17,105 |  | 50               | % |  | $                 | 16,147           |  | 61     | %                |  | 6  | % |  | $ | 47,964 |  | 50  | % |  | $ | 54,592 |  | 60  | % |  | (12 | )%
|Direct and others         |  |                    | 16,826 |  | 50               | % |  |                   | 10,158           |  | 39     | %                |  | 66 | % |  |   | 48,417 |  | 50  | % |  |   | 36,672 |  | 40  | % |  | 32  | % 
|                          |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |    |   |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|Total                     |  | $                  | 33,931 |  | 100              | % |  | $                 | 26,305           |  | 100    | %                |  |    |   |  | $ | 96,381 |  | 100 | % |  | $ | 91,264 |  | 100 | % |  |     |   
|                          |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |    |   |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   

For the three months ended December 27, 2009, net sales to our distributors for
which we recognize revenue on the sell-through method included $0.2 million in sales of Hifn and Galazar products. Net sales to direct customers and other distributors for the third quarter of fiscal 2010 included $7.1 million in sales of Hifn and
Galazar products.

For the nine months ended December 27, 2009, net sales to our distributors for which we recognize
revenue on the sell-through method included $0.7 million in sales of Hifn and Galazar products. Net sales to direct customers and other distributors for the first nine months of fiscal 2010 included $19.7 million in sales of Hifn and Galazar
products.

Net Sales by Geography

Our net sales by geography in dollars and as a percentage of net sales were as follows for the fiscal periods presented (in thousands):



|           |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|---------- |  | ------------------ | ------ |  | ---------------- | - |  | ----------------- | ---------------- |  | ------ | ---------------- |  | --- | -- |  | - | ------ |  | --- | - |  | - | ------ |  | --- | - |  | --- | --
|           |  | Three Months Ended |        |  | Change           |   |  | Nine Months Ended |                  |  | Change |                 
|           |  | December 27,2009   |        |  | December 28,2008 |   |  |                   | December 27,2009 |  |        | December 28,2008 |  |    
|Net Sales: |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|Americas   |  | $                  | 9,449  |  | 28               | % |  | $                 | 6,838            |  | 26     | %                |  | 38  | %  |  | $ | 25,332 |  | 26  | % |  | $ | 23,444 |  | 26  | % |  | 8   | % 
|Asia       |  |                    | 19,580 |  | 58               | % |  |                   | 13,251           |  | 50     | %                |  | 48  | %  |  |   | 57,381 |  | 60  | % |  |   | 47,979 |  | 52  | % |  | 20  | % 
|Europe     |  |                    | 4,902  |  | 14               | % |  |                   | 6,216            |  | 24     | %                |  | (21 | )% |  |   | 13,668 |  | 14  | % |  |   | 19,841 |  | 22  | % |  | (31 | )%
|           |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   
|Total      |  | $                  | 33,931 |  | 100              | % |  | $                 | 26,305           |  | 100    | %                |  |     |    |  | $ | 96,381 |  | 100 | % |  | $ | 91,264 |  | 100 | % |  |     |   
|           |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |     |   |  |   |        |  |     |   |  |     |   

For the three months ended December 27, 2009, net sales in the Americas, Asia
and Europe included $3.3 million, $3.3 million and $0.7 million, respectively, of sales of Hifn and Galazar products.

For the
nine months ended December 27, 2009, net sales in the Americas, Asia and Europe included $8.8 million, $10.2 million and $1.4 million, respectively, of sales of Hifn and Galazar products.



29



---

##### Table of Contents

The increase in Asia for both the three and nine months ended December 27, 2009 as
compared to the same periods a year ago was primarily due to increased sales to our China customers and distributors, which included $2.7 million and $8.6 million, respectively, in sales of Hifn and Galazar products.

The decrease in Europe for both the three and nine months ended December 27, 2009 as compared to the same periods a year ago was
primarily a result of lower sales to two key customers.

Gross Profit

Our gross profit in dollars and as a percentage of net sales was as follows for the fiscal periods presented (in thousands):



|                                              |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |   |  |   |        |  |    |   |  |   |        |  |    |   |  |     |   
|--------------------------------------------- |  | ------------------ | ------ |  | ---------------- | - |  | ----------------- | ---------------- |  | ------ | ---------------- |  | --- | - |  | - | ------ |  | -- | - |  | - | ------ |  | -- | - |  | --- | --
|                                              |  | Three Months Ended |        |  | Change           |   |  | Nine Months Ended |                  |  | Change |                 
|                                              |  | December 27,2009   |        |  | December 28,2008 |   |  |                   | December 27,2009 |  |        | December 28,2008 |  |    
|Net Sales                                     |  | $                  | 33,931 |  |                  |   |  | $                 | 26,305           |  |        |                  |  |     |   |  | $ | 96,381 |  |    |   |  | $ | 91,264 |  |    |   |  |     |   
|Cost of sales:                                |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |   |  |   |        |  |    |   |  |   |        |  |    |   |  |     |   
|Cost of sales                                 |  |                    | 15,686 |  | 46               | % |  |                   | 14,819           |  | 56     | %                |  | 6   | % |  |   | 46,060 |  | 48 | % |  |   | 48,392 |  | 53 | % |  | (5  | )%
|Fair value adjustment of acquired inventories |  |                    | 92     |  |                 | % |  |                   |                 |  |       | %                |  | 100 | % |  |   | 2,326  |  | 2  | % |  |   |       |  |   | % |  | 100 | % 
|Amortization of acquired intangible assets    |  |                    | 1,108  |  | 4                | % |  |                   | 782              |  | 3      | %                |  | 42  | % |  |   | 4,015  |  | 4  | % |  |   | 2,693  |  | 3  | % |  | 49  | % 
|                                              |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |   |  |   |        |  |    |   |  |   |        |  |    |   |  |     |   
|Gross profit                                  |  | $                  | 17,045 |  | 50               | % |  | $                 | 10,704           |  | 41     | %                |  |     |   |  | $ | 43,980 |  | 46 | % |  | $ | 40,179 |  | 44 | % |  |     |   
|                                              |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |   |  |   |        |  |    |   |  |   |        |  |    |   |  |     |   

Gross profit represents net sales less cost of sales. Cost of sales includes:



| |  |  | the cost of purchasing finished silicon wafers manufactured by independent foundries;
| | - |  | -------------------------------------------------------------------------------------



| |  |  | the costs associated with assembly, packaging, test, quality assurance and product yields;
| | - |  | ------------------------------------------------------------------------------------------



| |  |  | the cost of personnel and equipment associated with manufacturing support and engineering;
| | - |  | ------------------------------------------------------------------------------------------



| |  |  | the cost of stock-based compensation associated with manufacturing engineering and support personnel;
| | - |  | -----------------------------------------------------------------------------------------------------



| |  |  | the amortization of purchased intangible assets;
| | - |  | ------------------------------------------------



| |  |  | the amortization of inventory fair value of inventories acquired;
| | - |  | -----------------------------------------------------------------



| |  |  | the provision for excess and obsolete inventory; and
| | - |  | ----------------------------------------------------



| |  |  | the sale of previously reserved inventory.
| | - |  | ------------------------------------------

The increase in gross profit, as a percentage of net sales, for the three months ended December 27, 2009 as compared to the prior period, was primarily due to sales of Hifn and Galazar products which
include higher margins and cost improvements on inventory components, partially offset by an increase in amortization of acquired intangible assets.

The increase in gross profit, as a percentage of net sales, for the nine months ended December 27, 2009 as compared to the prior period, was primarily due to the higher margins on Hifn and Galazar
products, improved margins on serial transceiver and power management products, a lower provision for excess and obsolete partially offset by amortization of the fair value of inventories acquired from Hifn and Galazar and manufacturing
inefficiencies associated with shipping lower product volume as compared to the prior year.



30



---

##### Table of Contents

Other Costs and Expenses



|                                          |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |    |   |  |   |        |  |    |   |  |     |  
|----------------------------------------- |  | ------------------ | ------ |  | ---------------- | - |  | ----------------- | ---------------- |  | ------ | ---------------- |  | --- | -- |  | - | ------ |  | -- | - |  | - | ------ |  | -- | - |  | --- | -
|                                          |  | Three Months Ended |        |  | Change           |   |  | Nine Months Ended |                  |  | Change |                 
|                                          |  | December 27,2009   |        |  | December 28,2008 |   |  |                   | December 27,2009 |  |        | December 28,2008 |  |    
|Net Sales                                 |  | $                  | 33,931 |  |                  |   |  | $                 | 26,305           |  |        |                  |  |     |    |  | $ | 96,381 |  |    |   |  | $ | 91,264 |  |    |   |  |     |  
|R&D expense:                              |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |    |   |  |   |        |  |    |   |  |     |  
|R&Dbase                                  |  | $                  | 10,444 |  | 31               | % |  | $                 | 7,064            |  | 27     | %                |  | 48  | %  |  | $ | 31,820 |  | 33 | % |  | $ | 21,924 |  | 24 | % |  | 45  | %
|Stock-based compensation                  |  |                    | 467    |  | 1                | % |  |                   | 392              |  | 1      | %                |  | 19  | %  |  |   | 1,701  |  | 2  | % |  |   | 1,231  |  | 1  | % |  | 38  | %
|Amortization expenseacquired intangibles |  |                    | 635    |  | 2                | % |  |                   | 199              |  | 1      | %                |  | 219 | %  |  |   | 1,858  |  | 2  | % |  |   | 725    |  | 1  | % |  | 156 | %
|Acquisition related costs                 |  |                    | 128    |  |                 | % |  |                   | 437              |  | 2      | %                |  | (71 | )% |  |   | 877    |  | 1  | % |  |   | 437    |  | 1  | % |  | 101 | %
|                                          |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |    |   |  |   |        |  |    |   |  |     |  
|Total R&D expense                         |  | $                  | 11,674 |  | 34               | % |  | $                 | 8,092            |  | 31     | %                |  | 44  | %  |  | $ | 36,256 |  | 38 | % |  | $ | 24,317 |  | 27 | % |  | 49  | %
|                                          |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |    |   |  |   |        |  |    |   |  |     |  
|SG&A expense:                             |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |    |   |  |   |        |  |    |   |  |     |  
|SG&Abase                                 |  | $                  | 9,462  |  | 28               | % |  | $                 | 7,772            |  | 30     | %                |  | 22  | %  |  | $ | 29,608 |  | 31 | % |  | $ | 26,710 |  | 29 | % |  | 11  | %
|Stock-based compensation                  |  |                    | 751    |  | 2                | % |  |                   | 768              |  | 3      | %                |  | (2  | )% |  |   | 2,225  |  | 2  | % |  |   | 2,012  |  | 2  | % |  | 11  | %
|Amortization expenseacquired intangibles |  |                    | 178    |  |                 | % |  |                   | 122              |  |       | %                |  | 46  | %  |  |   | 499    |  | 1  | % |  |   | 446    |  | 1  | % |  | 12  | %
|Acquisition related costs                 |  |                    | 297    |  | 1                | % |  |                   | 437              |  | 2      | %                |  | (32 | )% |  |   | 4,843  |  | 5  | % |  |   | 978    |  | 1  | % |  | 395 | %
|                                          |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |    |   |  |   |        |  |    |   |  |     |  
|Total SG&A expense                        |  | $                  | 10,688 |  | 31               | % |  | $                 | 9,099            |  | 35     | %                |  | 17  | %  |  | $ | 37,175 |  | 39 | % |  | $ | 30,146 |  | 33 | % |  | 23  | %
|                                          |  |                    |        |  |                  |   |  |                   |                  |  |        |                  |  |     |    |  |   |        |  |    |   |  |   |        |  |    |   |  |     |  

Research and Development (R&D)

Our R&D costs consist primarily of:



| |  |  | the salaries, stock-based compensation, and related expenses of employees engaged in product research, design and development activities;
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------------



| |  |  | costs related to engineering design tools, mask tooling costs, software amortization, test hardware, engineering supplies and services, and use of
in-house test equipment;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | amortization of acquired intangible assets; and
| | - |  | -----------------------------------------------



| |  |  | facilities expenses.
| | - |  | --------------------

For the three and nine months ended December 27, 2009, base R&D expenses increased $3.4 million and $9.9 million, respectively, as compared to the same periods a year ago, primarily due to
increased labor expenses, higher mask tooling costs and software amortization and equipment depreciation due to the growth of our company as a result of the acquisition of Hifn and Galazar partially offset by $1.0 million and $3.4 million,
respectively, in the reimbursement of certain costs under a research and development contract.

Stock-based compensation
expense recorded in R&D expenses was $0.5 million and $1.7 million for the three and nine months ended December 27, 2009, respectively, as compared to $0.4 million and $1.2 million, respectively, for the same periods a year ago. The
increase in stock-based compensation expense as compared to the same periods a year ago was primarily due to new stock option and restricted stock unit (RSU) grants made to former Hifn and Galazar employees and the incremental costs
associated with the employee stock option exchange in November 2008.

The growth in amortization expense  acquired
intangibles for both the three and nine months ended December 27, 2009 as compared to prior periods a year ago relates to the amortization of intangible assets associated with the Hifn and Galazar acquisitions.

Acquisition related costs for the nine months ended December 27, 2009 are primarily associated with accelerated depreciation of $0.6
million relating to shortened remaining lives of equipment acquired in the Hifn acquisition and employee severance costs.



31



---

##### Table of Contents

Selling, General and Administrative (SG&A)

SG&A expenses consist primarily of:



| |  |  | salaries, stock-based compensation and related expenses;
| | - |  | --------------------------------------------------------



| |  |  | sales commissions;
| | - |  | ------------------



| |  |  | professional and legal fees;
| | - |  | ----------------------------



| |  |  | amortization of acquired intangible assets such as distributor relationships, tradenames/trademarks and customer relationships; and
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------



| |  |  | acquisition related costs.
| | - |  | --------------------------

For the three and nine months ended December 27, 2009, base SG&A expenses increased $1.7 million and $2.9 million, respectively, as compared to the same periods a year ago, primarily due to
increased labor expenses and equipment depreciation due to the growth of our company as a result of the acquisition of Hifn, and to a lesser extent, Galazar.

Stock-based compensation expense recorded in SG&A expenses was $0.8 million and $2.2 million for the three and the nine months ended December 29, 2009, respectively, as compared to $0.8 million
and $2.0 million, respectively, for the same periods a year ago. The increase in stock-based compensation expense for the nine months ended December 27, 2009 as compared to the same period a year ago was primarily due to new stock option and
RSU grants made to former Hifn and Galazar employees and the costs associated with the employee stock option exchange in November 2008.

Acquisition related costs for the three months ended December 27, 2009 are primarily related to professional fees in connection with the ongoing efforts to integrate the acquired companies and
employee severance costs.

Acquisition related costs for the nine months ended December 27, 2009 primarily consist of
$2.8 million in investment banker, printing, legal and other professional fees that are recorded as expenses related to business combinations and the accelerated depreciation of $0.8 million relating to shortened remaining lives of equipment
acquired from Hifn and employee separation costs of $0.8 million, and building exit and moving costs of $0.3 million related to the Hifn Los Gatos facility.

Other Income and Expenses, Net



|                                  |  |                    |        |   |                  |    |    |                   |                  |        |        |                  |    |    |  |      |    |  |   |        |   |  |    |    |  |   |        |   |  |    |    |  |     |   
|--------------------------------- |  | ------------------ | ------ | - | ---------------- | -- | -- | ----------------- | ---------------- | ------ | ------ | ---------------- | -- | -- |  | ---- | -- |  | - | ------ | - |  | -- | -- |  | - | ------ | - |  | -- | -- |  | --- | --
|                                  |  | Three Months Ended |        |   | Change           |    |    | Nine Months Ended |                  |        | Change |                 
|                                  |  | December 27,2009   |        |   | December 28,2008 |    |    |                   | December 27,2009 |        |        | December 28,2008 |    |   
|Net Sales                         |  | $                  | 33,931 |   |                  |    |    |                   | $                | 26,305 |        |                  |    |    |  |      |    |  | $ | 96,381 |   |  |    |    |  | $ | 91,264 |   |  |    |    |  |     |   
|                                  |  |                    |        |   |                  |    |    |                   |                  |       
|Interest income and other, net    |  |                    | 1,835  |   |                  | 5  | %  |                   |                  | 2,570  |        |                  | 10 | %  |  | (29  | )% |  |   | 5,289  |   |  | 5  | %  |  |   | 7,774  |   |  | 9  | %  |  | (32 | )%
|Interest expense                  |  |                    | (323   | ) |                  | (1 | )% |                   |                  | (266   | )      |                  | (1 | )% |  | 21   | %  |  |   | (973   | ) |  | (1 | )% |  |   | (927   | ) |  | (1 | )% |  | 5   | % 
|Impairment charges on investments |  |                    |       |   |                  |   | %  |                   |                  | (34    | )      |                  |   | %  |  | (100 | )% |  |   | (317   | ) |  |   | %  |  |   | (1,487 | ) |  | (2 | )% |  | (79 | )%

Interest Income and Other, Net

Interest income and other, net primarily consists of:



| |  |  | interest income;
| | - |  | ----------------



| |  |  | sublease income;
| | - |  | ----------------



| |  |  | foreign exchange gains or losses; and
| | - |  | -------------------------------------



| |  |  | gains or losses on the sale or disposal of equipment.
| | - |  | -----------------------------------------------------



32



---

##### Table of Contents

For the three and nine months ended December 27, 2009, interest income and other, net
decreased $0.7 million and $2.5 million, respectively, as compared to the same periods a year ago, primarily attributable to a decrease in interest income as a result of lower invested cash balances, lower yield of the investments and increased
investment management fees as we transitioned the internally managed portion of our portfolio to our professional money managers.

Our Hillview Facility, which we originally leased from Mission West Properties, L.P., was sublet to a subtenant in April 2008. The sublease expires on March 31, 2011 with average annual rent of approximately $1.4 million. The sublease
also requires the subtenant to pay certain operating costs associated with subleasing the facility. The sublease income for the three and nine months ended December 27, 2009 was $0.4 million and $1.1 million, respectively. See Part I,
Item 1, Notes to Condensed Consolidated Financial Statements,Note 15  Lease Financing Obligation.

Interest Expense

In fiscal year 2008, in connection with the acquisition of Sipex, we assumed a lease
financing obligation related to the Hillview Facility. We have accounted for this sale and leaseback transaction as a financing transaction which is included in the Long-term lease financing obligations line item on our condensed
consolidated balance sheets. The effective interest rate is 8.2%.

We have acquired engineering design tools (design
tools) under capital leases. We acquired $5.2 million of design tools in December 2007 under a four-year license and $3.7 million of design tools in November 2008 under a three-year license, which were accounted for as capital leases and
recorded in the Property, plant and equipment, net line item on the condensed consolidated balance sheets. The related design tool obligations were included in the Long-term lease financing obligations line on our condensed
consolidated balance sheets. The effective interest rates for the design tools are 7.25% for the four-year tools and 4.0% for the three-year tools.

Interest expense for the Hillview Facility lease financing and the design tools lease obligations was $0.3 million and $1.0 million for the three and nine months ended December 27, 2009,
respectively.

Impairment Charges on Investments

We periodically review and determine whether our investments with unrealized loss positions are other-than-temporarily impaired. We regularly
review our investments in unrealized loss positions for other-than-temporary impairments. This evaluation includes, but is not limited to, significant quantitative and qualitative assessments and estimates regarding credit ratings, collateralized
support, the length of time and significance of a securitys loss position, our intent to not sell the security and whether it is more likely than not that we will not have to sell the security before recovery of its cost basis. Realized gains
and losses and declines in value of our investments, both marketable and non-marketable, judged to be other-than-temporary are reported in the Impairment charges on investments line item in the condensed consolidated statements of
operations.

Our long-term investment consists of our investment in Skypoint Telecom Fund II (US), L.P. (Skypoint
Fund). Skypoint Fund is a venture capital fund that invested primarily in private companies in the telecommunications and/or networking industry. We account for this non-marketable equity investment under the cost method. We periodically
review and determine whether the investment is other-than-temporarily impaired, in which case the investment is written down to its impaired value.

In the second quarter of fiscal 2010, we analyzed the fair value of the underlying investments of Skypoint Fund and concluded a portion of the carrying value was other-than-temporarily impaired and
recorded an impairment charge of $154,000 in addition to the $72,000 recorded in the first quarter of fiscal 2010.

In the
second quarter of fiscal 2010 an investment in GSAA Home Equity, with a cost of $425,000, was downgraded from an AAA rating to a CCC rating. As a result of the reduction in the rating and quantitative analysis showing an increase in the default rate
and decrease in prepayment rate of the investment, we recorded an other-than-temporary impairment charge of $91,000 during the second quarter of fiscal 2010.

Benefit from Income Taxes

During the three months ended December 27,
2009 and December 28, 2008, we recorded an income tax benefit of $43,000 and $70,000, respectively. During the nine months ended December 27, 2009 and December 28, 2008, we recorded an income tax benefit of $0.7 million and $0.1
million, respectively. During the three and nine months ended December 27, 2009, the tax benefit was primarily due to benefits recorded for a true-up adjustment of prior year tax expense and net operating losses.



33



---

##### Table of Contents

LIQUIDITY AND CAPITAL RESOURCES



|                                                         |  |                        |         |   |                  |   |         |  
|-------------------------------------------------------- |  | ---------------------- | ------- | - | ---------------- | - | ------- | -
|                                                         |  | Nine Months Ended      |        
|                                                         |  | December 27,2009       |         |   | December 28,2008 |  
|                                                         |  | (dollars in thousands) |        
|Cash and cash equivalents                                |  | $                      | 22,166  |   |                  | $ | 70,835  |  
|Short-term investments                                   |  |                        | 196,090 |   |                  |   | 186,646 |  
|                                                         |  |                        |         |   |                  |   |         |  
|Total cash, cash equivalents, and short-term investments |  | $                      | 218,256 |   |                  | $ | 257,481 |  
|                                                         |  |                        |         |   |                  |   |         |  
|Percentage of total assets                               |  |                        | 66      | % |                  |   | 75      | %
|                                                         |  |                       
|Net cash (used in) provided by operating activities      |  | $                      | (1,392  | ) |                  | $ | 3,996   |  
|Net cash used in investing activities                    |  |                        | (63,761 | ) |                  |   | (43,420 | )
|Net cash used in financing activities                    |  |                        | (1,683  | ) |                  |   | (11,757 | )
|                                                         |  |                        |         |   |                  |   |         |  
|Net decrease in cash and cash equivalents                |  | $                      | (66,836 | ) |                  | $ | (51,181 | )
|                                                         |  |                        |         |   |                  |   |         |  

Our net loss was $24.8 million for the nine months ended December 27, 2009.
After adjustments for non-cash items and changes in working capital, we used $1.4 million of cash through operating activities.

Significant non-cash charges included:



| |  |  | depreciation and amortization expenses of $15.6 million;
| | - |  | --------------------------------------------------------



| |  |  | stock-based compensation expense of $4.3 million; and
| | - |  | -----------------------------------------------------



| |  |  | provision for sales returns and allowances of $7.9 million.
| | - |  | -----------------------------------------------------------

Working capital changes included:



| |  |  | a $13.2 million increase in accounts receivable primarily due to an increase in revenues and timing of customer payments at the end of the quarter;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | a fair value adjustments of acquired inventories included in cost of sales of $2.3 million;
| | - |  | -------------------------------------------------------------------------------------------



| |  |  | a $4.7 million decrease in inventory primarily as a result of increased shipments and a reduction in material and assembly purchases;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------



| |  |  | a $1.4 million increase in accounts payable due to the timing of every other week check runs; and
| | - |  | -------------------------------------------------------------------------------------------------



| |  |  | a $2.4 million increase in deferred income due to increased distributors shipments.
| | - |  | ------------------------------------------------------------------------------------

In the nine months ended December 27, 2009, net cash used in investing activities reflects purchases of short-term marketable
securities, net of sales and maturities, of $14.3 million, together with $4.7 million in purchases of property, plant and equipment and intellectual property.

As previously discussed, we acquired Hifn and Galazar on April 3, 2009 and June 17, 2009, respectively. Cash used in these acquisitions, net of cash acquired, was $40.3 million and $4.4 million,
respectively.

We acquire shares of our outstanding common stock in the open market from time to time to partially offset
dilution from our stock awards program, to increase our return on our invested capital and to bring our cash to a more appropriate level for our company. We may continue to utilize our stock purchase program described below, which would reduce our
cash, cash equivalents and/or short-term investments available to fund future operations and to meet other liquidity requirements.

On August 28, 2007, we established a share repurchase plan (2007 SRP) and authorized the repurchase of up to $100 million of our common stock. During the nine months ended December 27, 2009, we did not repurchase any
of our common stock under the 2007 SRP. As of December 27, 2009, the remaining authorized amount available under the 2007 SRP was $11.8 million with no termination date.



34



---

##### Table of Contents

We repurchased a total of 1.6 million shares of our common stock at an aggregate cost
of $13.4 million under the 2007 SRP during the nine months ended December 28, 2008.

To date, inflation has not had a
significant impact on our operating results.

We anticipate that we will continue to finance our operations with cash flows
from operations, existing cash and investment balances, and some combination of long-term debt and/or lease financing and additional sales of equity securities. The combination and sources of capital will be determined by management based on our
needs and prevailing market conditions.

The following table summarizes our investments in cash equivalents and marketable
securities (in thousands):



|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        
|------------------------------------- |  | ----------------- | ----------- | ---------- | ------------ | ----- | ---------- | - | ---- | - |  | - | -------
|                                      |  | December 27, 2009
|                                      |  | AmortizedCost     |             | Unrealized |              |       | Fair Value
|                                      |  |                   | Gross Gains |            | Gross Losses |       |           
|Money market funds                    |  | $                 | 19,846      |            | $            |      |            | $ |     |   |  | $ | 19,846 
|Corporate bonds and commercial paper  |  |                   | 61,706      |            |              | 859   |            |   | (44  | ) |  |   | 62,521 
|U.S. government and agency securities |  |                   | 59,729      |            |              | 1,132 |            |   | (21  | ) |  |   | 60,840 
|Asset and mortgage-backed securities  |  |                   | 72,236      |            |              | 576   |            |   | (83  | ) |  |   | 72,729 
|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        
|Total investment                      |  | $                 | 213,517     |            | $            | 2,567 |            | $ | (148 | ) |  | $ | 215,936
|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        
|                                      | 
|                                      |  | March 29, 2009   
|                                      |  | AmortizedCost     |             | Unrealized |              |       | Fair Value
|                                      |  |                   | Gross Gains |            | Gross Losses |       |           
|Money market funds                    |  | $                 | 26,332      |            | $            |      |            | $ |     |   |  | $ | 26,332 
|Corporate bonds and commercial paper  |  |                   | 28,169      |            |              | 160   |            |   | (141 | ) |  |   | 28,188 
|U.S. government and agency securities |  |                   | 163,750     |            |              | 1,379 |            |   | (38  | ) |  |   | 165,091
|Asset and mortgage-backed securities  |  |                   | 35,070      |            |              | 317   |            |   | (364 | ) |  |   | 35,023 
|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        
|Total investment                      |  | $                 | 253,321     |            | $            | 1,856 |            | $ | (543 | ) |  | $ | 254,634
|                                      |  |                   |             |            |              |       |            |   |      |   |  |   |        

As of December 27, 2009, our fixed income investment securities included
asset-backed and mortgage-backed securities, that accounted for 8% and 26%, respectively, of our total investments. The asset-backed securities are comprised primarily of premium tranches of auto loans and credit card receivables, while our
mortgage-backed securities are primarily from federal agencies. We do not own auction rate securities nor do we own securities that are classified as sub-prime. As of the date of this Form 10-Q, we have sufficient liquidity and do not intend to sell
these securities nor realize any significant losses in the short term. As of December 27, 2009, the net unrealized gain of our asset-backed and mortgage-backed securities totaled $493,000.

We believe that our cash and cash equivalents, short-term marketable securities and cash flows from operations will be sufficient to satisfy
working capital requirements and capital equipment needs for at least the next 12 months. However, should the demand for our products decrease in the future, the availability of cash flows from operations may be limited, thus having a material
adverse effect on our financial condition or results of operations. From time to time, we evaluate potential acquisitions, strategic arrangements and equity investments complementary to our design expertise and market strategy, which may include
investments in wafer fabrication foundries. To the extent that we pursue or position ourselves to pursue these transactions, we could consume a significant portion of our capital resources or choose to seek additional equity or debt financing. There
can be no assurance that additional financing could be obtained on terms acceptable to us or at all. The sale of additional equity or convertible debt could result in dilution to our stockholders.

RECENT ACCOUNTING PRONOUNCEMENTS

Please refer to Part I, Item 1. Financial Statements and Notes to Condensed Consolidated Financial Statements, Note 2 Recent Accounting Pronouncements.

OFF-BALANCE SHEET ARRANGEMENTS

As of December 27, 2009, we had no off-balance sheet arrangements as defined in Item 303(a)(4) of the SECs Regulation S-K.



35



---

##### Table of Contents

SUBSEQUENT EVENTS

Please refer to Part I, Item 1. Financial Statements and Notes to Condensed Consolidated Financial Statements, Note 20Subsequent Events.

CONTRACTUAL OBLIGATIONS AND COMMITMENTS

Our contractual obligations and commitments at December 27, 2009 were as follows (in thousands):



|                                                     |  |                        |        |                 |   |          |  |          |       |                  |   |    |  |   |  
|---------------------------------------------------- |  | ---------------------- | ------ | --------------- | - | -------- |  | -------- | ----- | ---------------- | - | -- |  | - | -
|                                                     |  | Payments due by period
|Contractual Obligations                              |  | Total                  |        | Less than1 year |   | 1-3years |  | 3-5years |       | More than5 years
|Purchase commitment (1)                              |  | $                      | 12,176 |                 | $ | 11,676   |  | $        | 500   |                  | $ |   |  | $ | 
|Long-term lease financing obligation (2)             |  |                        | 7,942  |                 |   | 5,122    |  |          | 2,820 |                  |   |   |  |   | 
|Lease obligations (3)                                |  |                        | 1,149  |                 |   | 651      |  |          | 498   |                  |   |   |  |   | 
|Long-term investment commitments (Skypoint Fund) (4) |  |                        | 474    |                 |   | 474      |  |          |      |                  |   |   |  |   | 
|Remediation commitment (5)                           |  |                        | 147    |                 |   | 97       |  |          | 10    |                  |   | 40 |  |   | 
|                                                     |  |                        |        |                 |   |          |  |          |       |                  |   |    |  |   |  
|Total                                                |  | $                      | 21,888 |                 | $ | 18,020   |  | $        | 3,828 |                  | $ | 40 |  | $ | 
|                                                     |  |                        |        |                 |   |          |  |          |       |                  |   |    |  |   |  



|      |  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
|----- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Note: |  | The table above excludes the liability for unrecognized income tax benefit of approximately $3.5 million as of December 27, 2009 since we cannot predict with reasonable
reliability the timing of cash settlements with the respective taxing authorities.                                                                                                                                                                                                                                                     
|      | 
|(1)   |  | We place purchase orders with wafer foundries and other vendors as part of our normal course of business. We expect to receive and pay for wafers, capital equipment and various
service contracts over the next 12 to 18 months from our existing cash balances.                                                                                                                                                                                                                                               
|(2)   |  | Excludes approximately $12.2 million estimated final obligation settlement with the lessor by returning the Hillview facility at the end of the lease term due on our Hillview
facility in Milpitas, California under a 5-year Standard Form Lease agreement that we signed with Mission West Properties, L.P. on March 9, 2006, as amended on August 25, 2007. Includes licensing agreements related to engineering design
software of $6.1 million as well as $1.8 million related to our Hillview facilities.
|(3)   |  | Includes lease payments related to worldwide offices and buildings.                                                                                                                                                                                                                                                                                                                                                                                                                                             
|(4)   |  | The commitment related to the Skypoint Fund does not have a set payment schedule and thus will become payable upon request from the Funds General Partner.                                                                                                                                                                                                                                                                                                                                                     
|(5)   |  | The commitment relates to the environmental monitoring and remediation activities of Micro Power Systems, Inc.                                                                                                                                                                                                                                                                                                                                                                                                  



|ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|------- | ----------------------------------------------------------

Foreign Currency Fluctuations.We are exposed to foreign currency fluctuations primarily through our foreign operations. This exposure is the result of foreign operating expenses being denominated
in foreign currency. Operational currency requirements are typically forecasted for a one-month period. If there is a need to hedge this risk, we may enter into transactions to purchase currency in the open market or enter into forward currency
exchange contracts.

If our foreign operations forecasts are overstated or understated during periods of currency volatility,
we could experience unanticipated currency gains or losses. At December 27, 2009, we did not have significant foreign currency denominated net assets or net liabilities positions, and had no foreign currency contracts outstanding.

Investment Risk and Interest Rate Sensitivity. We maintain investment portfolio holdings of various issuers, types, and maturity
dates with various banks and investment banking institutions. The market value of these investments on any given day during the investment term may vary as a result of market interest rate fluctuations. Our investment portfolio consisted of cash
equivalents, money market funds and fixed income securities of $215.9 million as of December 27, 2009 and $254.6 million as of March 29, 2009. These securities, like all fixed income instruments, are subject to interest rate risk and will
vary in value as market interest rates fluctuate. If market interest rates were to increase or decline immediately and uniformly by less than 10% from levels as of December 27, 2009, the increase or decline in the fair value of the portfolio
would not be material. At December 27, 2009, the difference between the fair market value and the underlying cost of the investments portfolio was a net unrealized gain of $2.4 million.



36



---

##### Table of Contents

Our short-term investments are classified as available-for-sale securities and
the cost of securities sold is based on the specific identification method. At December 27, 2009, short-term investments consisted of asset and mortgage-backed securities, corporate bonds and government agency securities of $196.1 million.



|ITEM 4. | CONTROLS AND PROCEDURES
|------- | -----------------------

Evaluation of
Disclosure Controls and Procedures (Disclosure Controls)

We evaluated the effectiveness of the design and
operation of our Disclosure Controls, as defined by the rules and regulations of the SEC (the Evaluation), as of the end of the period covered by this Quarterly Report on Form 10-Q. This Evaluation was performed under the supervision and
with the participation of management, including our Chief Executive Officer (the CEO), as principal executive officer, and Chief Financial Officer (the CFO), as principal financial officer.

Attached as Exhibits 31.1 and 31.2 of this Quarterly Report on Form 10-Q are the certifications of the CEO and the CFO, respectively, in
compliance with Section 302 of the Sarbanes-Oxley Act of 2002 (the Certifications). This section of the Quarterly Report on Form 10-Q provides information concerning the Evaluation referred to in the Certifications and should be
read in conjunction with the Certifications.

Disclosure Controls are controls and procedures designed to ensure that
information required to be disclosed in the reports filed or submitted under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods as specified in the SECs rules and forms. In
addition, Disclosure Controls are designed to ensure the accumulation and communications of information required to be disclosed in reports filed or submitted under the Securities Exchange Act of 1934, as amended, to our management, including the
CEO and CFO, to allow timely decisions regarding required disclosure.

Based on the Evaluation, our CEO and CFO have concluded
that our Disclosure Controls are effective as of December 27, 2009.

Inherent Limitations on the Effectiveness of Disclosure Controls

Our management, including the CEO and CFO, does not expect that our Disclosure Controls will prevent all errors and all
fraud. Disclosure Controls, no matter how well conceived, managed, utilized and monitored, can provide only reasonable assurance that the objectives of such controls are met. Therefore, because of the inherent limitation of Disclosure Controls, no
evaluation of such controls can provide absolute assurance that all control issues and instances of fraud, if any, within us have been detected.

Changes in Internal Control over Financial Reporting

We have completed our acquisitions of Hifn on
April 3, 2009 and Galazar on June 17, 2009. We are currently in the process of integrating Exars, Hifns and Galazars internal controls and procedures, and therefore, have excluded those controls and procedures in Hifn and
Galazar. At this time, we anticipate that the fiscal year 2010 management report, under Section 404 of the Sarbanes-Oxley Act of 2002, will include Hifn and Galazar.

There has been no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably
likely to materially affect, our internal control over financial reporting.



37



---

##### Table of Contents

PART IIOTHER INFORMATION



|ITEM 1. | LEGAL PROCEEDINGS
|------- | -----------------

The
disclosure in Notes to Condensed Consolidated Financial Statements, Note 17 Legal Proceedings contained in Part I, Item 1. Financial Statements is hereby incorporated by reference.



|ITEM 1A. | RISK FACTORS
|-------- | ------------

Global capital, credit
market, employment, and general economic conditions, and resulting declines in consumer confidence and spending, could have a material adverse effect on our business, operating results, and financial condition.

Periodic declines or fluctuations in the U.S. dollar, corporate profits, interest rates, and inflation, lower spending, the impact of
conflicts throughout the world, terrorist acts, natural disasters, volatile energy costs, the outbreak of communicable diseases and other geopolitical factors, have had, and may continue to have, a negative impact on the U.S. and global economies.
Volatility and disruption in the global capital and credit markets have led to a tightening of business credit and liquidity, a contraction of consumer credit, business failures, higher unemployment, and declines in consumer confidence and spending
in the United States and internationally. If global economic and financial market conditions, currently showing early signs of recovery, deteriorate or remain weak for an extended period of time, many related factors could have a material
adverse effect on our business, operating results, and financial condition, including the following:



| |  |  | slower spending and market fluctuations in our industry may result in reduced demand for our products, reduced orders for our products, order
cancellations, lower revenues, increased inventories, and lower gross margins;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | we may be unable to predict the strength or duration of market conditions or the effects of consolidation of our customers in their industries, which
may result in project delays or cancellations;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | we may be unable to find suitable investments that are safe, liquid, and provide a reasonable return resulting in lower interest income or longer
investment horizons, and disruptions to capital markets or the banking system may also impair the value of investments or bank deposits we currently consider safe or liquid;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the failure of financial institution counterparties to honor their obligations to us under credit instruments could jeopardize our ability to rely on
and benefit from those instruments, and our ability to replace those instruments on the same or similar terms may be limited under poor market conditions;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | continued volatility in the markets and prices for commodities and raw materials we use in our products and in our supply chain could have a material
adverse effect on our costs, gross margins, and profitability;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | if distributors of our products experience declining revenues, or experience difficulty obtaining financing in the capital and credit markets to
purchase our products, it could result in reduced orders for our products, order cancellations, inability to timely meet payment obligations to us, extended payment terms, higher accounts receivable, reduced cash flows, greater expense associated
with collection efforts, and increased bad debt expense;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | if distributors of our products experience severe financial difficulty, some may become insolvent and cease business operations, which could reduce the
availability of our products to customers;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | if contract manufacturers or foundries of our products or other participants in our supply chain experience difficulty obtaining financing in the
capital and credit markets to purchase raw materials or to finance general working capital needs, it may result in delays or non-delivery of shipments of our products;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | potential shutdowns or over capacity constraints by our third-party foundry, assembly and test subcontractors due to slow business conditions could
result in longer lead-times, higher buffer inventory levels and degraded on-time delivery performance; and
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the current macroeconomic environment also limits our visibility into future purchases by our customers and renewals of existing agreements, which may
necessitate changes to our business model.
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



38



---

##### Table of Contents

Our financial results may fluctuate significantly because of a number of factors, many of which are
beyond our control.

Our financial results may fluctuate significantly as a result of a number of factors, many of which
are difficult or impossible to control or predict, which include:



| |  |  | the cyclical nature of the semiconductor industry;
| | - |  | --------------------------------------------------



| |  |  | difficulty in predicting revenues and ordering the correct mix of products from suppliers due to limited visibility provided by customers and channel
partners;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | fluctuations of our revenue and gross profits due to the mix of product sales as our margins vary by product;
| | - |  | -------------------------------------------------------------------------------------------------------------



| |  |  | the effect of the timing of sales by our resellers on our reported results as a result of our sell-through revenue recognition policies; and
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the reduction, rescheduling, cancellation or timing of orders by our customers, distributors and channel partners due to, among others, the following
factors:
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | management of customer, subcontractor and/or channel inventory;
| | - |  | ---------------------------------------------------------------



| |  |  | delays in shipments from our subcontractors causing supply shortages;
| | - |  | ---------------------------------------------------------------------



| |  |  | inability of our subcontractors to provide quality products, in adequate quantities and in a timely manner;
| | - |  | -----------------------------------------------------------------------------------------------------------



| |  |  | dependency on a single product with a single customer and/or distributor;
| | - |  | -------------------------------------------------------------------------



| |  |  | volatility of demand for equipment sold by our large customers, which in turn, introduces demand volatility for our products;
| | - |  | -----------------------------------------------------------------------------------------------------------------------------



| |  |  | disruption in customer demand as customers change or modify their complex subcontract manufacturing supply chain;
| | - |  | -----------------------------------------------------------------------------------------------------------------



| |  |  | disruption in customer demand due to technical or quality issues with our devices or components in their system;
| | - |  | ----------------------------------------------------------------------------------------------------------------



| |  |  | the inability of our customers to obtain components from their other suppliers;
| | - |  | -------------------------------------------------------------------------------



| |  |  | disruption in sales or distribution channels;
| | - |  | ---------------------------------------------



| |  |  | our ability to maintain and expand distributor relationships;
| | - |  | -------------------------------------------------------------



| |  |  | changes in sales and implementation cycles for our products;
| | - |  | ------------------------------------------------------------



| |  |  | the ability of our suppliers and customers to remain solvent, obtain financing or fund capital expenditures as a result of the current global
recession;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | risks associated with entering new markets;
| | - |  | -------------------------------------------



| |  |  | the announcement or introduction of products by our existing competitors or new competitors;
| | - |  | --------------------------------------------------------------------------------------------



| |  |  | loss of market share by our customers;
| | - |  | --------------------------------------



| |  |  | competitive pressures on selling prices or product availability;
| | - |  | ----------------------------------------------------------------



| |  |  | pressures on selling prices overseas due to foreign currency exchange fluctuations;
| | - |  | -----------------------------------------------------------------------------------



| |  |  | erosion of average selling prices coupled with the inability to sell newer products with higher average selling prices, resulting in lower overall
revenue and margins;
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | delays in product design releases;
| | - |  | ----------------------------------



| |  |  | market and/or customer acceptance of our products;
| | - |  | --------------------------------------------------



| |  |  | consolidation among our competitors, our customers and/or our customers customers;
| | - |  | -----------------------------------------------------------------------------------



| |  |  | changes in our customers end user concentration or requirements;
| | - |  | -----------------------------------------------------------------



| |  |  | loss of one or more major customers;
| | - |  | ------------------------------------



| |  |  | significant changes in ordering pattern by major customers;
| | - |  | -----------------------------------------------------------



39



---

##### Table of Contents

| |  |  | our or our channel partners ability to maintain and manage appropriate inventory levels;
| | - |  | -----------------------------------------------------------------------------------------



| |  |  | the availability and cost of materials and services, including foundry, assembly and test capacity, needed by us from our foundries and other
manufacturing suppliers;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | disruptions in our or our customers supply chain due to natural disasters, fire, outbreak of communicable diseases, labor disputes, civil unrest
or other reasons;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | delays in successful transfer of manufacturing processes to our subcontractors;
| | - |  | -------------------------------------------------------------------------------



| |  |  | fluctuations in the manufacturing output, yields, and capacity of our suppliers;
| | - |  | --------------------------------------------------------------------------------



| |  |  | fluctuation in suppliers capacity due to reorganization, relocation or shift in business focus, financial constraints, or other reasons;
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------------



| |  |  | problems, costs, or delays that we may face in shifting our products to smaller geometry process technologies and in achieving higher levels of design
and device integration;
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | our ability to successfully introduce and transfer into production new products and/or integrate new technologies;
| | - |  | ------------------------------------------------------------------------------------------------------------------



| |  |  | increased manufacturing costs;
| | - |  | ------------------------------



| |  |  | higher mask tooling costs associated with advanced technologies;
| | - |  | ----------------------------------------------------------------



| |  |  | the amount and timing of our investment in research and development;
| | - |  | --------------------------------------------------------------------



| |  |  | costs and business disruptions associated with stockholder or regulatory issues;
| | - |  | --------------------------------------------------------------------------------



| |  |  | the timing and amount of employer payroll tax to be paid on our employees gains on stock options exercised;
| | - |  | ------------------------------------------------------------------------------------------------------------



| |  |  | inability to generate profits to utilize net operating losses;
| | - |  | --------------------------------------------------------------



| |  |  | increased costs and time associated with compliance with new accounting rules or new regulatory requirements;
| | - |  | -------------------------------------------------------------------------------------------------------------



| |  |  | changes in accounting or other regulatory rules, such as the requirement to record assets and liabilities at fair value;
| | - |  | ------------------------------------------------------------------------------------------------------------------------



| |  |  | fluctuations in interest rates and/or market values of our marketable securities;
| | - |  | ---------------------------------------------------------------------------------



| |  |  | litigation costs associated with the defense of suits brought or complaints made against us; and
| | - |  | ------------------------------------------------------------------------------------------------



| |  |  | change in or continuation of certain tax provisions.
| | - |  | ----------------------------------------------------

Our expense levels are based, in part, on expectations of future revenues and are, to a large extent, fixed in the short-term. Our revenues are difficult to predict and at times we have failed to achieve
revenue expectations. We may be unable to adjust spending in a timely manner to compensate for any unexpected revenue shortfall. If revenue levels are below expectations for any reason, operating results are likely to be materially adversely
affected.

If we fail to develop, introduce or enhance products that meet evolving market needs or which are necessitated by technological
advances, or we are unable to grow revenues, then our business, financial condition and results of operations could be materially and adversely impacted.

The markets for our products are characterized by a number of factors, some of which are listed below:



| |  |  | changing technologies;
| | - |  | ----------------------



| |  |  | evolving and competing industry standards;
| | - |  | ------------------------------------------



| |  |  | changing customer requirements;
| | - |  | -------------------------------



| |  |  | increasing price pressure;
| | - |  | --------------------------



| |  |  | increasing product development costs;
| | - |  | -------------------------------------



| |  |  | long design-to-production cycles;
| | - |  | ---------------------------------



| |  |  | competitive solutions;
| | - |  | ----------------------



40



---

##### Table of Contents

| |  |  | fluctuations in capital equipment spending levels and/or deployment;
| | - |  | --------------------------------------------------------------------



| |  |  | rapid adjustments in customer demand and inventory;
| | - |  | ---------------------------------------------------



| |  |  | increasing functional integration;
| | - |  | ----------------------------------



| |  |  | moderate to slow growth;
| | - |  | ------------------------



| |  |  | frequent product introductions and enhancements;
| | - |  | ------------------------------------------------



| |  |  | changing competitive landscape (consolidation, financial viability); and
| | - |  | ------------------------------------------------------------------------



| |  |  | finite market windows for product introductions.
| | - |  | ------------------------------------------------

Our growth depends in part on our successful continued development and acceptance of new products for our core markets. We must: (i) anticipate customer and market requirements and changes in
technology and industry standards; (ii) properly define and develop new products on a timely basis; (iii) gain access to and use technologies in a cost-effective manner; (iv) have suppliers produce quality products; (v) continue
to expand our technical and design expertise; (vi) introduce and cost-effectively manufacture new products on a timely basis; (vii) differentiate our products from our competitors offerings; and (viii) gain customer acceptance
of our products. In addition, we must continue to have our products designed into our customers future products and maintain close working relationships with key customers to define and develop new products that meet their evolving needs.
Moreover, we must respond in a rapid and cost-effective manner to shifts in market demands, the trend towards increasing functional integration and other changes. Migration from older products to newer products may result in volatility of earnings
as revenues from older products decline and revenues from newer products begin to be achieved.

Products for our
customers applications are based on continually evolving industry standards and new technologies. Our ability to compete will depend in part on our ability to identify and ensure compliance with these industry standards. The emergence of new
standards could render our products incompatible. We could be required to invest significant time, effort and expenses to develop and qualify new products to ensure compliance with industry standards.

The process of developing and supporting new products is complex, expensive and uncertain, and if we fail to accurately predict and
understand our customers changing needs and emerging technological trends, our business may be harmed. In addition, we may make significant investments to modify new products according to input from our customers who may choose a
competitors or an internal solution, or cancel their projects. We may not be able to identify new product opportunities successfully, develop and bring to market new products, achieve design wins, ensure when and which design wins actually get
released to production, or respond effectively to technological changes or product announcements by our competitors. In addition, we may not be successful in developing or using new technologies or may incorrectly anticipate market demand and
develop products that achieve little or no market acceptance. Our pursuit of technological advances may require substantial time and expense and may ultimately prove unsuccessful. Failure in any of these areas may materially and adversely harm our
business, financial condition and results of operations.

If we are unable to convert a significant portion of our design wins into
revenue, our business, financial condition and results of operations could be materially and adversely impacted.

We
continue to secure design wins for new and existing products. Such design wins are necessary for revenue growth. However, many of our design wins may never generate revenues if their end-customer projects are unsuccessful in the market place or the
end-customer terminates the project, which may occur for a variety of reasons. Mergers, consolidations or cost reduction activities among our customers may lead to termination of certain projects before the associated design win generates revenue.
If design wins do generate revenue, the time lag between the design win and meaningful revenue is typically between six months to greater than eighteen months. If we fail to convert a significant portion of our design wins into substantial revenue,
our business, financial condition and results of operations could be materially and adversely impacted. Under current deteriorating global economic conditions, our design wins could be delayed even longer than the typical lag period and our eventual
revenue could be less than anticipated from products that were introduced within the last eighteen to thirty-six months, which would likely materially and adversely affect our business, financial condition and results of operations.



41



---

##### Table of Contents

We have made and in the future may make acquisitions and significant strategic equity investments, which
may involve a number of risks. If we are unable to address these risks successfully, such acquisitions and investments could have a materially adverse effect on our business, financial condition and results of operations.

We have undertaken a number of strategic acquisitions and investments recently and may do so from time to time in the future. The risks
involved with these acquisitions and investments include:



| |  |  | the possibility that we may not receive a favorable return on our investment or incur losses from our investment or the original investment may become
impaired;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | revenues or synergies could fall below projections or fail to materialize as assumed;
| | - |  | -------------------------------------------------------------------------------------



| |  |  | failure to satisfy or set effective strategic objectives;
| | - |  | ---------------------------------------------------------



| |  |  | our assumption of known or unknown liabilities or other unanticipated events or circumstances; and
| | - |  | --------------------------------------------------------------------------------------------------



| |  |  | the diversion of managements attention from day-to-day operations of the business and the resulting potential disruptions to the ongoing
business.
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------

Additional risks involved with acquisitions include:



| |  |  | difficulties in integrating and managing various operations such as sales, engineering, marketing, and operations;
| | - |  | ------------------------------------------------------------------------------------------------------------------



| |  |  | difficulties in incorporating or leveraging acquired technologies and intellectual property rights in new products;
| | - |  | -------------------------------------------------------------------------------------------------------------------



| |  |  | difficulties or delays in the transfer of manufacturing flows and supply chains of products of acquired businesses;
| | - |  | -------------------------------------------------------------------------------------------------------------------



| |  |  | failure to retain and integrate key personnel;
| | - |  | ----------------------------------------------



| |  |  | failure to retain and maintain relationships with existing customers, distributors, channel partners and other parties;
| | - |  | -----------------------------------------------------------------------------------------------------------------------



| |  |  | failure to manage and operate multiple geographic locations both effectively and efficiently;
| | - |  | ---------------------------------------------------------------------------------------------



| |  |  | failure to coordinate research and development activities to enhance and develop new products and services in a timely manner that optimize the assets
and resources of the combined company;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | difficulties in creating uniform standards, controls (including internal control over financial reporting), procedures, policies and information
systems;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | unexpected capital equipment outlays and continuing expenses related to technical and operational integration;
| | - |  | --------------------------------------------------------------------------------------------------------------



| |  |  | difficulties in entering markets or retaining current markets in which we have limited or no direct prior experience and where competitors in such
markets may have stronger market positions;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | insufficient revenues to offset increased expenses associated with acquisitions;
| | - |  | --------------------------------------------------------------------------------



| |  |  | under-performance problems with an acquired company;
| | - |  | ----------------------------------------------------



| |  |  | issuance of common stock that would dilute our current stockholders percentage ownership;
| | - |  | ------------------------------------------------------------------------------------------



| |  |  | reduction in liquidity and interest income on lower cash balances;
| | - |  | ------------------------------------------------------------------



| |  |  | recording of goodwill and intangible assets that will be subject to periodic impairment testing and potential impairment charges against our future
earnings;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | incurring amortization expenses related to certain intangible assets;
| | - |  | ---------------------------------------------------------------------



| |  |  | the opportunity cost associated with committing capital in such investments;
| | - |  | ----------------------------------------------------------------------------



| |  |  | incurring large and immediate write-offs; and
| | - |  | ---------------------------------------------



42



---

##### Table of Contents

| |  |  | being subject to litigation.
| | - |  | ----------------------------

Additional risks involved with strategic equity investments include:



| |  |  | the possibility of litigation resulting from these types of investments;
| | - |  | ------------------------------------------------------------------------



| |  |  | the possibility that we may not receive a financial return on our investments or incur losses from these investments;
| | - |  | ---------------------------------------------------------------------------------------------------------------------



| |  |  | a changed or poorly executed strategic plan; and
| | - |  | ------------------------------------------------



| |  |  | the opportunity cost associated with committing capital in such investments.
| | - |  | ----------------------------------------------------------------------------

We may not address these risks successfully without substantial expense, delay or other operational or financial problems, or at all. Any
delays or other such operations or financial problems could adversely impact our business, financial condition and results of operations.

The complexity of our products may lead to errors, defects and bugs, which could subject us to significant costs or damages and adversely affect market acceptance of our products.

Although we, our customers and our suppliers rigorously test our products, they may contain undetected errors, performance weaknesses,
defects or bugs when first introduced or as new versions are released. If any of our products contain production defects, reliability, quality or compatibility problems that are significant to our customers, our reputation may be damaged and
customers may be reluctant to continue to buy our products, which could adversely affect our ability to retain and attract new customers. In addition, these defects or bugs could interrupt or delay sales of affected products, which could adversely
affect our results of operations.

If defects or bugs are discovered after commencement of commercial production, we may be
required to make significant expenditures of capital and other resources to resolve the problems. This could result in significant additional development costs and the diversion of technical and other resources from our other development efforts. We
could also incur significant costs to repair or replace defective products or may agree to be liable for certain damages incurred. These costs or damages could have a material adverse effect on our financial condition and results of operations.

We derive a substantial portion of our revenues from distributors, especially from our two primary distributors, Future Electronics Inc.
(Future), a related party, and Nu Horizons Electronics Corp. (Nu Horizons). Our revenues would likely decline significantly if our primary distributors elected not to promote or sell our products or if they elected to cancel,
reduce or defer purchases of our products.

Our distributors rely heavily on the availability of short-term capital at
reasonable rates to fund their ongoing operations. If this capital is not available, or is only available on onerous terms, certain distributors may not be able to pay for inventory received or we may experience a reduction in orders from these
distributors, which would likely cause our revenue to decline and materially and adversely impact our business, financial condition and results of operations.

Future and Nu Horizons have historically accounted for a significant portion of our revenues, and they are our two primary distributors worldwide. We anticipate that sales of our products to these
distributors will continue to account for a significant portion of our revenues. The loss of either Future or Nu Horizons as a distributor, for any reason, or a significant reduction in orders from either of them would materially and adversely
affect our operating results, business and financial condition.

Sales to Future and Nu Horizons are made under agreements
that provide protection against price reduction for their inventory of our products. As such, we could be exposed to significant liability if the inventory value of the products held by Future and Nu Horizons declined dramatically. Our distributor
agreements with Future and Nu Horizons do not contain minimum purchase commitments. As a result, Future and Nu Horizons could cease purchasing our products with short notice or cease distributing these products. In addition, they may defer or cancel
orders without penalty, which would likely cause our revenues to decline and materially and adversely impact our business, financial condition and results of operations.

If we are unable to accurately forecast demand for our products, we may be unable to efficiently manage our inventory.

Due to the absence of substantial non-cancelable backlog, we typically plan our production and inventory levels based on customer forecasts, internal evaluation of customer demand and current backlog,
which can fluctuate substantially. As a consequence of inaccuracies inherent in forecasting, inventory imbalances periodically occur that result in surplus amounts of some of our products and shortages of others. Such shortages can adversely impact
customer relations and surpluses can result in larger-than-desired inventory levels, which can adversely impact our financial position. Due to the unpredictability of global economic conditions and increased difficulty in forecasting demand for our
products, we could experience an increase in inventory levels.



43



---

##### Table of Contents

If our distributors or sales representatives stop selling or fail to successfully promote our products,
our business, financial condition and results of operations could be adversely impacted.

We sell many of our products
through sales representatives and distributors, many of which sell directly to OEMs, contract manufacturers and end customers. Our non-exclusive distributors and sales representatives may carry our competitors products, which could adversely
impact or limit sales of our products. Additionally, they could reduce or discontinue sales of our products or may not devote the resources necessary to sell our products in the volumes and within the time frames that we expect. Our agreements with
distributors contain limited provisions for return of our products, including stock rotations whereby distributors may return a percentage of their purchases from us based upon a percentage of their most recent three months of shipments. In
addition, in certain circumstances upon termination of the distributor relationship, distributors may return some portion of their prior purchases. The loss of business from any of our significant distributors or the delay of significant orders from
any of them, even if only temporary, could materially and adversely harm our business, financial conditions and results of operations.

Moreover, we depend on the continued viability and financial resources of these distributors and sales representatives, some of which are small organizations with limited working capital. In turn, these distributors and sales
representatives are subject to general economic and semiconductor industry conditions. We believe that our success will continue to depend on these distributors and sales representatives. If some or all of our distributors and sales representatives
experience financial difficulties, or otherwise become unable or unwilling to promote and sell our products, our business, financial condition and results of operations could be adversely impacted.

We depend in part on the continued service of our key engineering and management personnel and our ability to identify, hire, incentivize and retain
qualified personnel. If we lose key employees or fail to identify, hire, incentivize and retain these individuals, our business, financial condition and results of operations could be materially and adversely impacted.

Our future success depends, in part, on the continued service of our key design engineering, technical, sales, marketing and executive
personnel and our ability to identify, hire, motivate and retain other qualified personnel.

Under certain circumstances,
including a company acquisition or business downturn, current and prospective employees may experience uncertainty about their future roles with us. Volatility or lack of positive performance in our stock price and the ability to offer equity
compensation to as many key employees or in amounts consistent with past practices, as a result of regulations regarding the expensing of equity awards, may also adversely affect our ability to retain key employees, all of whom have been granted
equity awards. In addition, competitors may recruit employees, as is common in the high tech sector. If we are unable to retain personnel that are critical to our future operations, we could face disruptions in operations, loss of existing
customers, loss of key information, expertise or know-how, and unanticipated additional recruitment and training costs.

Competition for skilled employees having specialized technical capabilities and industry-specific expertise is intense and continues to be a considerable risk inherent in the markets in which we compete. At times competition for such
employees has been particularly notable in California and the Peoples Republic of China (PRC). Further, the PRC historically has different managing principles from Western style management and financial reporting concepts and
practices, as well as in modern banking, computer and other control systems, making the successful identification and employment of qualified personnel particularly important, and hiring and retaining a sufficient number of such qualified employees
may be difficult. As a result of these factors, we may experience difficulty in establishing management, legal and financial controls, collecting financial data, books of account and records and instituting business practices that meet Western
standards, which could negatively affect our business and results of operations.

Our employees are employed at-will, which
means that they can terminate their employment at any time. Our international locations are subject to local labor laws, significantly different from U.S. labor laws, which may under certain conditions result in large separation costs upon
termination. The failure to recruit and retain, as necessary, key design engineers, technical, sales, marketing and executive personnel could harm our business, financial condition and results of operations.

Occasionally, we enter into agreements that expose us to potential damages that exceed the value of the agreement.

We have given certain customers increased indemnification for product deficiencies that is in excess of our standard limited warranty
indemnification and could possibly result in greater costs, in excess of the original contract value. In an attempt to limit this liability, we have purchased an errors and omissions insurance policy to partially offset these potential additional
costs; however, our insurance coverage could be insufficient to prevent us from suffering material losses if the indemnification amounts are large enough.



44



---

##### Table of Contents

We may be exposed to additional credit risk as a result of the addition of significant direct customers
through recent acquisitions.

From time to time one of our customers has contributed more than 10% of our quarterly net
sales. A number of our customers are OEMs, or the manufacturing subcontractors of OEMs, which might result in an increase in concentrated credit risk with respect to our trade receivables.

Any error in our sell-through revenue recognition judgment or estimates could lead to inaccurate reporting of our net sales, gross profit, deferred
income and allowances on sales to distributors and net income.

Sell-through revenue recognition is highly dependent on
receiving pertinent and accurate data from our distributors in a timely fashion. Distributors provide us periodic data regarding the product, price, quantity, and end customer when products are resold as well as the quantities of our products they
still have in stock. We must use estimates and apply judgment to reconcile distributors reported inventories to their activities. Any error in our judgment could lead to inaccurate reporting of our net sales, gross profit, deferred income and
allowances on sales to distributors and net income.

Because a significant portion of our total assets were, and may again be with future
potential acquisitions, represented by goodwill and other intangible assets, which are subject to mandatory annual impairment evaluations, we could be required to write-off some or all of our goodwill and other intangible assets, which may adversely
impact our financial condition and results of operations.

A significant portion of the purchase price for any business
combination may be allocated to identifiable tangible and intangible assets and assumed liabilities based on estimated fair values at the date of consummation. As required by GAAP, the excess purchase price, if any, over the fair value of these
assets less liabilities typically would be allocated to goodwill. We evaluate goodwill for impairment on an annual basis or whenever events and changes in circumstances suggest that the carrying amount may not be recoverable. We typically conduct
our annual analysis of our goodwill in the fourth quarter of our fiscal year. In-process research and development (IPR&D) asset is considered an indefinite-lived intangible asset and is not subject to amortization. IPR&D must be
tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. The impairment test consists of a comparison of the fair value of the IPR&D with its carrying amount. If the
carrying amount of the IPR&D exceeds its fair value, an impairment loss must be recognized in an amount equal to that excess. After an impairment loss is recognized, the adjusted carrying amount of the IPR&D will be its new accounting basis.
Subsequent reversal of a previously recognized impairment loss is prohibited. Intangible assets that are subject to amortization are reviewed for impairment on an annual basis or whenever events and changes in circumstances suggest that the carrying
amount may not be recoverable.

The assessment of goodwill and other intangible assets impairment is a subjective process.
Estimations and assumptions regarding future performance, results of our operations and comparability of our market capitalization and its net book value will be used. Changes in estimates and assumptions could have an adverse impact on our
financial conditions and results of operations.

Our business may be adversely impacted if we fail to effectively utilize and incorporate
acquired technology.

We have acquired and may in the future acquire intellectual property in order to accelerate our time
to market for new products. Acquisitions of intellectual property may involve risks such as successful technical integration into new products, market acceptance of new products and achievement of planned return on investment. Successful technical
integration in particular requires a variety of factors which we may not currently have, such as available technical staff with sufficient time to devote to integration, the requisite skill sets to understand the acquired technology and the
necessary support tools to effectively utilize the technology. The timely and efficient integration of acquired technology may be adversely impacted by inherent design deficiencies or application requirements. The potential failure of or delay in
product introduction utilizing acquired intellectual property could lead to an impairment of capitalized intellectual property acquisition costs.

If we are unable to compete effectively with existing or new competitors, we will experience fewer customer orders, reduced revenues, reduced gross margins and lost market share.

We compete in markets that are intensely competitive, and which are subject to both rapid technological change, continued price erosion and
changing business terms with regard to risk allocation. Our competitors include many large domestic and foreign companies that have substantially greater financial, technical and management resources, name recognition and leverage than we have. As a
result, they may be able to adapt more quickly to new or emerging technologies and changes in customer requirements or to devote greater resources to promote the sale of their products.

We have experienced increased competition at the design stage, where customers evaluate alternative solutions based on a number of factors,
including price, performance, product features, technologies, and availability of long-term product supply and/or roadmap guarantee. Additionally, we experience, in some cases, severe pressure on pricing from some of our competitors or on-going cost
reduction expectations from customers. Such circumstances may make some of our products unattractive due to price or



45



---

##### Table of Contents

performance measures and result in losing our design opportunities or causing a decrease in our revenue and margins. Also, competition from new companies in emerging economy countries with
significantly lower costs could affect our selling price and gross margins. In addition, if competitors in Asia reduce prices on commodity products, it would adversely affect our ability to compete effectively in that region. Specifically, we have
licensed rights to Hangzhou Silan Microelectronics Co. Ltd. and Hangzhou Silan Integrated Circuit Co. Ltd. (collectively Silan) in China to market our commodity interface products that could reduce our sales in the future should they
become a meaningful competitor. Loss of competitive position could result in price reductions, fewer customer orders, reduced revenues, reduced gross margins and loss of market share, any of which would affect our operating results and financial
condition. To the extent that our competitors offer distributors or sales representatives more favorable terms, these distributors and sales representatives may decline to carry, or discontinue carrying, our products. Our business, financial
condition and results of operations could be harmed by any failure to maintain and expand our distribution network. Furthermore, many of our existing and potential customers internally develop solutions which attempt to perform all or a portion of
the functions performed by our products. To remain competitive, we continue to evaluate our manufacturing operations for opportunities for additional cost savings and technological improvements. If we or our contract partners are unable to
successfully implement new process technologies and to achieve volume production of new products at acceptable yields, our operating results and financial condition may be materially and adversely affected. Our future competitive performance depends
on a number of factors, including our ability to:



| |  |  | increase device performance and improve manufacturing yields;
| | - |  | -------------------------------------------------------------



| |  |  | accurately identify emerging technological trends and demand for product features and performance characteristics;
| | - |  | ------------------------------------------------------------------------------------------------------------------



| |  |  | develop and maintain competitive and reliable products;
| | - |  | -------------------------------------------------------



| |  |  | enhance our products by adding innovative features that differentiate our products from those of our competitors;
| | - |  | -----------------------------------------------------------------------------------------------------------------



| |  |  | bring products to market on a timely basis at competitive prices;
| | - |  | -----------------------------------------------------------------



| |  |  | respond effectively to new technological changes or new product announcements by others;
| | - |  | ----------------------------------------------------------------------------------------



| |  |  | adapt products and processes to technological changes;
| | - |  | ------------------------------------------------------



| |  |  | adopt or set emerging industry standards;
| | - |  | -----------------------------------------



| |  |  | meet changing customer requirements; and
| | - |  | ----------------------------------------



| |  |  | provide adequate technical service and support.
| | - |  | -----------------------------------------------

Our design, development and introduction schedules for new products or enhancements to our existing and future products may not be met. In addition, these products or enhancements may not achieve market
acceptance, or we may not be able to sell these products at prices that are favorable.

Affiliates of Future, Alonim Investments Inc. and
two of its affiliates (collectively Alonim), own approximately 17% of our common stock, and as such, Alonim is our largest stockholder. This ownership position will allow Future to significantly influence matters requiring
stockholders approval. Futures ownership may continue to increase as a percentage of our outstanding shares if we continue to repurchase our common stock. In addition, an executive officer of Future is on our board of directors, which
could lead to actual or perceived influence from Future.

An affiliate of Future, our largest distributor, owns a
significant percentage of our outstanding shares and Pierre Guilbault, the chief financial officer of Future, is a member of our board of directors. Due to its affiliates ownership of a significant percentage of our common stock, Future may be
able to exert strong influence over actions requiring the approval of our stockholders, including the election of directors, many types of change of control transactions and amendments to our charter documents. The significant ownership percentage
of Future could have the effect of delaying or preventing a change of control or otherwise discouraging a potential acquirer from obtaining control of us. Conversely, by virtue of Futures percentage ownership of our stock, Future could
facilitate a takeover transaction that our board of directors did not approve.

This relationship could also result in actual
or perceived attempts to influence management to take actions beneficial to Future which may or may not be beneficial to us or in our best interests. Future could attempt to obtain terms and conditions more favorable than those we would typically
provide our distributors because of its relationship with us. Any such actual or perceived preferential treatment could materially and adversely affect our business, financial condition and results of operations.



46



---

##### Table of Contents

We depend on third-party subcontractors to manufacture our products. We utilize wafer foundries for
processing our wafers and assembly and test subcontractors for manufacturing and testing our packaged products. Any disruption in or loss of subcontractors capacity to manufacture our products subjects us to a number of risks, including the
potential for an inadequate supply of products and higher materials costs. These risks may lead to delayed product delivery or increased costs, which could materially and adversely impact our business, financial condition and results of operations.

We do not own or operate a semiconductor fabrication facility or a foundry. We utilize various foundries for different
processes. Our products are based on Complementary Metal Oxide Semiconductor (CMOS) processes, bipolar processes and bipolar-CMOS (BiCMOS) processes. Chartered Semiconductor Manufacturing Ltd. (Chartered), located
in Singapore, manufactures the majority of the CMOS wafers from which our communications and UART products are produced. Episil Technologies, Inc. (Episil), located in Taiwan, and Silan, located in China, manufacture the majority of the
CMOS and bipolar wafers from which our power and serial products are produced. High Voltage BiCMOS power products are supplied by Polar Semiconductor (MN, USA) and Jazz Semiconductor (CA, USA). All of these foundries produce semiconductors for many
other companies (many of which have greater requirements than us), and therefore, we may not have access on a timely basis to sufficient capacity or certain process technologies and we do, from time to time, experience extended lead times on some
products. In addition, we rely on our foundries continued financial health and ability to continue to invest in smaller geometry manufacturing processes and additional wafer processing capacity.

Many of our new products are designed to take advantage of smaller geometry manufacturing processes. Due to the complexity and increased
cost of migrating to smaller geometries as well as process changes, we could experience interruptions in production or significantly reduced yields causing product introduction or delivery delays. If such delays occur, our products may have delayed
market acceptance or customers may select our competitors products during the design process.

New process technologies
or new products can be subject to especially wide variations in manufacturing yields and efficiency. There can be no assurance that our foundries or the foundries of our suppliers will not experience unfavorable yield variances or other
manufacturing problems that result in delayed product introduction or delivery delays.

We do not have long-term wafer supply
agreements with Chartered that would guarantee wafer quantities, prices, and delivery or lead times, but we do provide minimum purchase commitments to Silan and Episil in accordance with our supply agreements. Subject to any such minimum purchase
commitments, these foundries manufacture our products on a purchase order basis. We provide our foundries with rolling forecasts of our production requirements. However, the ability of our foundries to provide wafers is limited by the
foundries available capacity. There can be no assurance that our third-party foundries will allocate sufficient capacity to satisfy our requirements.

Furthermore, any sudden reduction or elimination of any primary source or sources of fully processed wafers could result in a material delay in the shipment of our products. Any delays or shortages will
materially and adversely impact our business, financial condition and operating results.

In addition, we may not continue to
do business with our foundries on terms as favorable as our current terms. Significant risks associated with our reliance on third-party foundries include:



| |  |  | consolidation in the industry leading to a change in control at key wafer suppliers;
| | - |  | ------------------------------------------------------------------------------------



| |  |  | the lack of assured process technology and wafer supply;
| | - |  | --------------------------------------------------------



| |  |  | limited control over quality assurance, manufacturing yields and production costs;
| | - |  | ----------------------------------------------------------------------------------



| |  |  | financial and operating stability of the foundries;
| | - |  | ---------------------------------------------------



| |  |  | limited control over delivery schedules;
| | - |  | ----------------------------------------



| |  |  | limited manufacturing capacity of the foundries; and
| | - |  | ----------------------------------------------------



| |  |  | potential misappropriation of our intellectual property.
| | - |  | --------------------------------------------------------

Our reliance on our wafer foundries and assembly and test subcontractors involves the following risks:



| |  |  | a manufacturing disruption or sudden reduction or elimination of any existing source or sources of semiconductor manufacturing materials or processes,
which might include the potential closure, change of ownership, change in business conditions or relationships, change of management or consolidation by one of our foundries;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



47



---

##### Table of Contents

| |  |  | disruption of manufacturing or assembly or test services due to relocation or limited capacity of the foundries or subcontractors;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------



| |  |  | inability to obtain or develop technologies needed to manufacture our products;
| | - |  | -------------------------------------------------------------------------------



| |  |  | extended time required to identify, qualify and transfer to alternative manufacturing sources for existing or new products or the possible inability to
obtain an adequate alternative;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | failure of our foundries or subcontractors to obtain raw materials and equipment;
| | - |  | ---------------------------------------------------------------------------------



| |  |  | increasing cost of raw materials and energy resulting in higher wafer or package costs;
| | - |  | ---------------------------------------------------------------------------------------



| |  |  | long-term financial and operating stability of the foundries, or their suppliers or subcontractors and their ability to invest in new capabilities and
expand capacity to meet increasing demand, to remain solvent, or to obtain financing in tight credit markets;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | continuing measures taken by our suppliers such as reductions in force, pay reductions, forced time off or shut down of production for extended periods
of time to reduce and/or control operating expenses in response to weakened and weakening customer demand;
| | - |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | subcontractors inability to transition to smaller package types or new package compositions;
| | - |  | ---------------------------------------------------------------------------------------------



| |  |  | a sudden, sharp increase in demand for semiconductor devices, which could strain the foundries or subcontractors manufacturing resources
and cause delays in manufacturing and shipment of our products;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | manufacturing quality control or process control issues, including reduced control over manufacturing yields, production schedules and product quality;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | disruption of transportation to and from Asia where most of our foundries and subcontractors are located;
| | - |  | ---------------------------------------------------------------------------------------------------------



| |  |  | embargoes or other regulatory limitations affecting the availability of raw materials, equipment or changes in tax laws, tariffs, services and freight
rates; and
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | compliance with local or international regulatory requirements.
| | - |  | ---------------------------------------------------------------

Other additional risks associated with subcontractors include:



| |  |  | subcontractors imposing higher minimum order quantities for substrates;
| | - |  | -----------------------------------------------------------------------



| |  |  | potential increase in assembly and test costs;
| | - |  | ----------------------------------------------



| |  |  | our board level product volume may not be attractive to preferred manufacturing partners, which could result in higher pricing or having to qualify an
alternative vendor;
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | difficulties in selecting, qualifying and integrating new subcontractors;
| | - |  | -------------------------------------------------------------------------



| |  |  | entry into take-or-pay agreements; and
| | - |  | ----------------------------------------



| |  |  | limited warranties from our subcontractors for products assembled and tested for us.
| | - |  | ------------------------------------------------------------------------------------



48



---

##### Table of Contents

Our stock price is volatile.

The market price of our common stock has fluctuated significantly to date. In the future, the market price of our common stock could be
subject to significant fluctuations due to, among other reasons:



| |  |  | our anticipated or actual operating results;
| | - |  | --------------------------------------------



| |  |  | announcements or introductions of new products by us or our competitors;
| | - |  | ------------------------------------------------------------------------



| |  |  | technological innovations by us or our competitors;
| | - |  | ---------------------------------------------------



| |  |  | loss of or changes to key executives;
| | - |  | -------------------------------------



| |  |  | product delays or setbacks by us, our customers or our competitors;
| | - |  | -------------------------------------------------------------------



| |  |  | potential supply disruptions;
| | - |  | -----------------------------



| |  |  | sales channel interruptions;
| | - |  | ----------------------------



| |  |  | concentration of sales among a small number of customers;
| | - |  | ---------------------------------------------------------



| |  |  | conditions in our customers markets and the semiconductor markets;
| | - |  | -------------------------------------------------------------------



| |  |  | the commencement and/or results of litigation;
| | - |  | ----------------------------------------------



| |  |  | changes in estimates of our performance by securities analysts;
| | - |  | ---------------------------------------------------------------



| |  |  | decreases in the value of our investments or long-lived assets, thereby requiring an asset impairment charge against earnings;
| | - |  | ------------------------------------------------------------------------------------------------------------------------------



| |  |  | repurchasing shares of our common stock;
| | - |  | ----------------------------------------



| |  |  | announcements of merger or acquisition transactions; and/or
| | - |  | -----------------------------------------------------------



| |  |  | general global economic and capital market conditions.
| | - |  | ------------------------------------------------------

In the past, securities and class action litigation has been brought against companies following periods of volatility in the market prices of their securities. We may be the target of one or more of
these class action suits, which could result in significant costs and divert managements attention, thereby harming our business, results of operations and financial condition.

In addition, at times the stock market has experienced and is currently experiencing extreme price, volume and value fluctuations that
affect the market prices of many high technology companies, including semiconductor companies, and that are unrelated or disproportionate to the operating performance of those companies. Any such fluctuations may harm the market price of our common
stock.

Our results of operations could vary as a result of the methods, estimations and judgments we use in applying our accounting
policies.

The methods, estimates and judgments we use in applying our accounting policies have a significant impact on our
results of operations. Such methods, estimates and judgments are, by their nature, subject to substantial risks, uncertainties, assumptions and changes in rulemaking by the regulatory bodies; and factors may arise over time that lead us to change
our methods, estimates, and judgments. Changes in those methods, estimates and judgments could significantly impact our results of operations. Our revenue reporting is highly dependent on receiving pertinent and accurate data from our distributors
in a timely fashion. Distributors provide us periodic data regarding the product, price, quantity and end customer when products are resold as well as the quantities of our products they still have in stock. We must use estimates and apply judgment
to reconcile distributors reported inventories to their activities. Any error in our judgment could lead to inaccurate reporting of our revenues, deferred income and allowances on sales to distributors and net income.



49



---

##### Table of Contents

The final determination of our income tax liability may be materially different from our income tax
provision, which could have an adverse effect on our results of operations.

Our future effective tax rates may be
adversely affected by a number of factors including:



| |  |  | the jurisdictions in which profits are determined to be earned and taxed;
| | - |  | -------------------------------------------------------------------------



| |  |  | the resolution of issues arising from tax audits with various tax authorities;
| | - |  | ------------------------------------------------------------------------------



| |  |  | changes in the valuation of our deferred tax assets and liabilities;
| | - |  | --------------------------------------------------------------------



| |  |  | adjustments to estimated taxes upon finalization of various tax returns;
| | - |  | ------------------------------------------------------------------------



| |  |  | increases in expenses not deductible for tax purposes, including write-offs of acquired in-process research and development and impairment of goodwill
in connection with acquisitions;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | changes in available tax credits;
| | - |  | ---------------------------------



| |  |  | changes in share-based compensation expense;
| | - |  | --------------------------------------------



| |  |  | changes in tax laws or the interpretation of such tax laws and changes in generally accepted accounting principles; and/or
| | - |  | --------------------------------------------------------------------------------------------------------------------------



| |  |  | the repatriation of non-U.S. earnings for which we have not previously provided for U.S. taxes.
| | - |  | -----------------------------------------------------------------------------------------------

Any significant increase in our future effective tax rates could adversely impact net income for future periods. In addition, the U.S.
Internal Revenue Service (IRS) and other tax authorities regularly examine our income tax returns. Our results of operations could be adversely impacted if these assessments or any other assessments resulting from the examination of our
income tax returns by the IRS or other taxing authorities are not resolved in our favor.

We have acquired significant Net
Operating Loss (NOL) carryforwards as a result of our acquisitions. The utilization of acquired NOL carryforwards is subject to the IRSs complex limitation rules that carry significant burdens of proof. Our eventual ability to
utilize our estimated NOL carryforwards is subject to IRS scrutiny and our future results may not benefit as a result of potential unfavorable IRS rulings.

On September 30, 2008, California enacted Assembly Bill 1452 which among other provisions, suspends net operating loss deductions for our fiscal years 2009 and 2010 and extends the carryforward
period of any net operating losses not utilized due to such suspension; adopts the federal 20-year net operating loss carryforward period; phases-in the federal two-year net operating loss carryback periods beginning in fiscal year 2012 and limits
the utilization of tax credits to 50 percent of a taxpayer's taxable income. We do not expect any impact to our effective tax rate or tax provision during fiscal year 2010 as the result of this law change.

Our engagement with foreign customers could cause fluctuations in our operating results, which could materially and adversely impact our business,
financial condition and results of operations.

International sales have accounted for, and will likely continue to account
for a significant portion of our revenues, which subjects us to the following risks, among others:



| |  |  | changes in regulatory requirements;
| | - |  | -----------------------------------



| |  |  | tariffs and other barriers;
| | - |  | ---------------------------



| |  |  | timing and availability of export or import licenses;
| | - |  | -----------------------------------------------------



| |  |  | disruption of services due to political, civil, labor, and economic instability;
| | - |  | --------------------------------------------------------------------------------



| |  |  | disruption of services due to natural disasters outside the United States;
| | - |  | --------------------------------------------------------------------------



| |  |  | disruptions to customer operations outside the United States due to the outbreak of communicable diseases;
| | - |  | ----------------------------------------------------------------------------------------------------------



| |  |  | difficulties in accounts receivable collections;
| | - |  | ------------------------------------------------



50



---

##### Table of Contents

| |  |  | difficulties in staffing and managing foreign subsidiary and branch operations;
| | - |  | -------------------------------------------------------------------------------



| |  |  | difficulties in managing sales channel partners;
| | - |  | ------------------------------------------------



| |  |  | difficulties in obtaining governmental approvals for communications and other products;
| | - |  | ---------------------------------------------------------------------------------------



| |  |  | limited intellectual property protection;
| | - |  | -----------------------------------------



| |  |  | foreign currency exchange fluctuations;
| | - |  | ---------------------------------------



| |  |  | the burden of complying with foreign laws and treaties; and
| | - |  | -----------------------------------------------------------



| |  |  | potentially adverse tax consequences.
| | - |  | -------------------------------------

In addition, because sales of our products have been denominated primarily in U.S. dollars, increases in the value of the U.S. dollar as compared with local currencies could make our products more
expensive to customers in the local currency of a particular country resulting in pricing pressures on our products. Increased international activity in the future may result in foreign currency denominated sales. Furthermore, because some of our
customers purchase orders and agreements are governed by foreign laws, we may be limited in our ability, or it may be too costly for us, to enforce our rights under these agreements and to collect damages, if awarded.

Because some of our integrated circuit products have lengthy sales cycles, we may experience substantial delays between incurring expenses related to
product development and the revenue derived from these products.

A portion of our revenue is derived from selling
integrated circuits to communications equipment vendors. Due to their product development cycle, we have typically experienced at least an eighteen-month time lapse between our initial contact with a customer and realizing volume shipments. We first
work with customers to achieve a design win, which may take nine months or longer. Our customers then complete their design, test and evaluation process and begin to ramp-up production, a period which typically lasts an additional nine months. The
customers of communications equipment manufacturers may also require a period of time for testing and evaluation, which may cause further delays. As a result, a significant period of time may elapse between our research and development efforts and
our realization of revenue, if any, from volume purchasing of our communications products by our customers. Due to the length of the communications equipment vendors product development cycle, the risks of project cancellation by our
customers, price erosion or volume reduction are common aspects of such engagements.

Our backlog may not result in revenue.

Due to the possibility of customer changes in delivery schedules and quantities actually purchased, cancellation of
orders, distributor returns or price reductions, our backlog at any particular date is not necessarily indicative of actual sales for any succeeding period. The still unsettled and weakened economy increases the risk of purchase order cancellations
or delays, product returns and price reductions. We may not be able to meet our expected revenue levels or results of operations if there is a reduction in our order backlog for any particular period and we are unable to replace those sales during
the same period.

Earthquakes and other natural disasters may damage our facilities or those of our suppliers and customers.

Our corporate headquarters in Fremont, California is located near major earthquake faults that have experienced seismic
activity. In addition, some of our customers and suppliers are in locations which may be subject to similar natural disasters. In the event of a major earthquake or other natural disaster near our headquarters, our operations could be disrupted.
Similarly, a major earthquake or other natural disaster affecting one or more of our major customers or suppliers could adversely impact the operations of those affected, which could disrupt the supply or sales of our products and harm our business.

Fixed operating expenses and our practice of ordering materials in anticipation of projected customer demand could make it difficult for
us to respond effectively to sudden swings in demand and result in higher than expected costs and excess inventory. Such sudden swings in demand could therefore have a material adverse impact on our business, financial condition and results of
operations.

Our operating expenses are relatively fixed in the short to medium term, and therefore, we have limited
ability to reduce expenses quickly and sufficiently in response to any revenue shortfall. In addition, we typically plan our production and inventory levels based on forecasts of customer demand, which is highly unpredictable and can fluctuate
substantially. From time to time, in response to anticipated long lead times to obtain inventory and materials from our outside suppliers and foundries, we may order materials in advance of anticipated customer demand. This advance ordering may
result in excess inventory levels or unanticipated



51



---

##### Table of Contents

inventory write-downs if expected orders fail to materialize. This incremental cost could have a materially adverse impact on our business, financial condition and results of operations.

We may be unable to protect our intellectual property rights, which could harm our competitive position.

Our ability to compete is affected by our ability to protect our intellectual property rights. We rely on a combination of patents,
trademarks, copyrights, mask work registrations, trade secrets, confidentiality procedures and non-disclosure and licensing arrangements to protect our intellectual property rights. Despite these efforts, we may be unable to protect our proprietary
information. Such intellectual property rights may not be recognized or if recognized, may not be commercially feasible to enforce. Moreover, our competitors may independently develop technology that is substantially similar or superior to our
technology.

More specifically, our pending patent applications or any future applications may not be approved, and any issued
patents may not provide us with competitive advantages or may be challenged by third parties. If challenged, our patents may be found to be invalid or unenforceable, and the patents of others may have an adverse effect on our ability to do business.
Furthermore, others may independently develop similar products or processes, duplicate our products or processes or design around any patents that may be issued to us.

We could be required to pay substantial damages or could be subject to various equitable remedies if it were proven that we infringed the intellectual property rights of others.

As a general matter, the semiconductor industry is characterized by ongoing litigation regarding patents and other intellectual property
rights. If a third party were to prove that our technology infringed its intellectual property rights, we could be required to pay substantial damages for past infringement and could be required to pay license fees or royalties on future sales of
our products. If we were required to pay such license fees whenever we sold our products, such fees could exceed our revenue. In addition, if it was proven that we willfully infringed a third partys proprietary rights, we could be held liable
for three times the amount of the damages that we would otherwise have to pay. Such intellectual property litigation could also require us to:



| |  |  | stop selling, incorporating or using our products that use the infringed intellectual property;
| | - |  | -----------------------------------------------------------------------------------------------



| |  |  | obtain a license to make, sell or use the relevant technology from the owner of the infringed intellectual property, which license may not be available
on commercially reasonable terms, if at all; and/or
| | - |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | redesign our products so as not to use the infringed intellectual property, which may not be technically or commercially feasible.
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------

The defense of infringement claims and lawsuits, regardless of their outcome, would likely be expensive and
could require a significant portion of managements time. In addition, rather than litigating an infringement matter, we may determine that it is in our best interests to settle the matter. Terms of a settlement may include the payment of
damages and our agreement to license technology in exchange for a license fee and ongoing royalties. These fees could be substantial. If we were required to pay damages or otherwise became subject to such equitable remedies, our business, financial
condition and results of operations would suffer. Similarly, if we were required to pay license fees to third parties based on a successful infringement claim brought against us, such fees could exceed our revenue.



|ITEM 6. | EXHIBITS
|------- | --------

(a) Exhibits required by
Item 601 of Regulation S-K

See the Exhibit Index, which follows the signature page to this Quarterly Report on
Form 10-Q.



52



---

##### Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Quarterly Report on
Form 10-Q of Exar Corporation to be signed on its behalf by the undersigned thereunto duly authorized.



|                 |  |    |  |                                                                                                                                          
|---------------- |  | -- |  | -----------------------------------------------------------------------------------------------------------------------------------------
|                 |  |    |  | EXAR CORPORATION                                                                                                                         
|                 |  |    |  | (Registrant)                                                                                                                             
|                 |  |   
|February 5, 2010 |  | By |  | /S/    PEDRO (PETE) P.
RODRIGUEZ                                                                                                         
|                 |  |    |  | Pedro (Pete) P. Rodriguez Chief Executive Officer, President and Director (On
the Registrants Behalf and as Principal Executive Officer)



53



---

##### Table of Contents

INDEX TO EXHIBITS



|               |  |                                                                                                                                                   |  |                           |  |         |  |             |  |               |  |  
|-------------- |  | ------------------------------------------------------------------------------------------------------------------------------------------------- |  | ------------------------- |  | ------- |  | ----------- |  | ------------- |  | -
|Exhibit Number |  | Exhibit                                                                                                                                           |  | Incorporated by Reference |  |        
|               |  | Form                                                                                                                                              |  | File No.                  |  | Exhibit |  | Filing Date |  | FiledHerewith
|               |  |                                                                                                                                                   |  |                           |  |        
|2.1            |  | Agreement and Plan of Merger, dated as of February 23, 2009, among Exar Corporation, Hybrid Acquisition Corp. and hi/fn, inc.                     |  | 8-K                       |  | 0-14225 |  | 2.1         |  | 02/27/2009    |  |  
|               |  |                                                                                                                                                   |  |                           |  |        
|3.1            |  | Amended and Restated Certificate of Incorporation                                                                                                 |  | 10-K                      |  | 0-14225 |  | 3.1         |  | 6/12/2007     |  |  
|               |  |                                                                                                                                                   |  |                           |  |        
|3.2            |  | Amended and Restated Bylaws                                                                                                                       |  | 8-K                       |  | 0-14225 |  | 3.1         |  | 12/10/2007    |  |  
|               |  |                                                                                                                                                   |  |                           |  |        
|31.1           |  | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a)                                                                  |  |                           |  |         |  |             |  |               |  | X
|               |  |                                                                                                                                                   |  |                           |  |        
|31.2           |  | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a)                                                                  |  |                           |  |         |  |             |  |               |  | X
|               |  |                                                                                                                                                   |  |                           |  |        
|32.1           |  | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |                           |  |         |  |             |  |               |  | X
|               |  |                                                                                                                                                   |  |                           |  |        
|32.2           |  | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |  |                           |  |         |  |             |  |               |  | X



54